{"product_id":"european-society-of-cardiology-ehra-2019","title":"European Society of Cardiology EHRA 2019","description":"\u003cheader class=\"section__headings section__headings___edc6e\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"field field-name-field-course-summary field-type-text-with-summary field-label-hidden\"\u003e\n\u003cdiv class=\"field-items\"\u003e\n\u003cdiv class=\"field-item even\"\u003e\n\u003cdiv class=\"card-header bg-transparent py-4 px-3\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003cdiv class=\"prod-title\"\u003e\n\u003ch3 class=\"product_title entry-title\"\u003eEuropean Society of Cardiology EHRA 2019\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eInclude: 454 videos + 797 pdfs, size: 168 GB\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTopics:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e10-year trends in the use of catheter ablation for the treatment ofVT versus other ablation procedures.pdf\u003c\/li\u003e\n\u003cli\u003e19 gene panel analysis for latvian arrhythmogenic right ventricular cardiomyopathy patients.pdf\u003c\/li\u003e\n\u003cli\u003e1969-2019 50 years since the first discovery of cardiac calcium current activation by adrenaline.mp4\u003c\/li\u003e\n\u003cli\u003e1969-2019 50 years since the first discovery of cardiac calcium current activation by adrenaline.pdf\u003c\/li\u003e\n\u003cli\u003e2019 Forecast.mp4\u003c\/li\u003e\n\u003cli\u003e2019 Forecast.pdf\u003c\/li\u003e\n\u003cli\u003e3D vectorcardiography confirms electrical synchronization achieved by dynamic programming of atrioventricular.pdf\u003c\/li\u003e\n\u003cli\u003e60 year male, cardiomyopathy, LVEF 35% and persistent atrial fibrillation.mp4\u003c\/li\u003e\n\u003cli\u003e60 year male, cardiomyopathy, LVEF 35% and persistent atrial fibrillation.pdf\u003c\/li\u003e\n\u003cli\u003eA combined mri and ECG-imaging investigation to determine the electrophysiological manifestation of cardiac.mp4\u003c\/li\u003e\n\u003cli\u003eA combined mri and ECG-imaging investigation to determine the electrophysiological manifestation of cardiac.pdf\u003c\/li\u003e\n\u003cli\u003eA feasibility study comparison of three dimensional noninvasive computer angiography with intaprocedural.pdf\u003c\/li\u003e\n\u003cli\u003eA long atrial electromechanical interval is associated with arrhythmia recurrence after catheter ablation.pdf\u003c\/li\u003e\n\u003cli\u003eA new low-dose fluoroscopy technique for minimizing radiation exposure during cardiac electronic device implantation.pdf\u003c\/li\u003e\n\u003cli\u003eA novel electrocardiographic sign to differentiate posteroseptal accessory pathways ablated from the right.mp4\u003c\/li\u003e\n\u003cli\u003eA novel electrocardiographic sign to differentiate posteroseptal accessory pathways ablated from the right.pdf\u003c\/li\u003e\n\u003cli\u003eA prospective randomised controlled trial of cardiac resynchronisation therapy guided by invasive LV dP dt.mp4\u003c\/li\u003e\n\u003cli\u003eA prospective randomised controlled trial of cardiac resynchronisation therapy guided by invasive LV dP dt.pdf\u003c\/li\u003e\n\u003cli\u003eA randomized clinical trial of cryoballoon vs. irrigated radiofrequency catheter ablation for atrial fibrillation.mp4\u003c\/li\u003e\n\u003cli\u003eA randomized clinical trial of cryoballoon vs. irrigated radiofrequency catheter ablation for atrial fibrillation.pdf\u003c\/li\u003e\n\u003cli\u003eA risk stratification scoring system for new-onset atrial fibrillation after ischemic stroke – A national cohort study.pdf\u003c\/li\u003e\n\u003cli\u003eA simple method to improve the reliability of echocardiography in patients with atrial fibrillation.pdf\u003c\/li\u003e\n\u003cli\u003eAblation of empirical and elicited non-pulmonary vein triggers.mp4\u003c\/li\u003e\n\u003cli\u003eAblation of empirical and elicited non-pulmonary vein triggers.pdf\u003c\/li\u003e\n\u003cli\u003eAblation of incisional atrial tachycardia – Tricks for various repaired congenital heart anatomies.mp4\u003c\/li\u003e\n\u003cli\u003eAblation of incisional atrial tachycardia – Tricks for various repaired congenital heart anatomies.pdf\u003c\/li\u003e\n\u003cli\u003eAblation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation – AVATAR AF.mp4\u003c\/li\u003e\n\u003cli\u003eAblation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation – AVATAR AF.pdf\u003c\/li\u003e\n\u003cli\u003eAblation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation – Discussion.mp4\u003c\/li\u003e\n\u003cli\u003eAblation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation – Discussion.pdf\u003c\/li\u003e\n\u003cli\u003eAbnormal atrial activity is it associated with obesity, obstrutive sleep apnea or both of them.pdf\u003c\/li\u003e\n\u003cli\u003eAccelerating clinical decisions by simplifying the analysis of ultra high-density ventricular tachycardia mapping.mp4\u003c\/li\u003e\n\u003cli\u003eAccelerating clinical decisions by simplifying the analysis of ultra high-density ventricular tachycardia mapping.pdf\u003c\/li\u003e\n\u003cli\u003eAccessory pathway localization using ultra high density mapping of the AV annulus.mp4\u003c\/li\u003e\n\u003cli\u003eAccessory pathway localization using ultra high density mapping of the AV annulus.pdf\u003c\/li\u003e\n\u003cli\u003eAccuracy of the late gadolinium enhancement cardiac magnetic resonance in the identification of electrical.pdf\u003c\/li\u003e\n\u003cli\u003eAcute and long-term success of catheter ablation of atypical atrial flutter in patients with previous pulmonary vein isolation.pdf\u003c\/li\u003e\n\u003cli\u003eAcute outcomes associated with mapping idiopathic vt using a high-density grid-style catheter.pdf\u003c\/li\u003e\n\u003cli\u003eAcute outcomes associated with mapping ischemic ventricular tachycardia using a novel high-density grid-style catheter.pdf\u003c\/li\u003e\n\u003cli\u003eAcute outcomes associated with mapping ventricular tachycardia in non-ischemic cardiomyopathy patients.pdf\u003c\/li\u003e\n\u003cli\u003eAdequate ICD treatments after the use of the wearable cardioverter-defibrillator.pdf\u003c\/li\u003e\n\u003cli\u003eAdvanced technologies for managing Atrial Fibrillation (AF) and Heart Failure (HF).mp4\u003c\/li\u003e\n\u003cli\u003eAdvanced technologies for managing Atrial Fibrillation (AF) and Heart Failure (HF).pdf\u003c\/li\u003e\n\u003cli\u003eAF-FICIENT 1 Trial – Discussion.mp4\u003c\/li\u003e\n\u003cli\u003eAF-FICIENT 1 Trial – Discussion.pdf\u003c\/li\u003e\n\u003cli\u003eAfterload dependence of left and right ventricular response to pacing delay optimization.mp4\u003c\/li\u003e\n\u003cli\u003eAfterload dependence of left and right ventricular response to pacing delay optimization.pdf\u003c\/li\u003e\n\u003cli\u003eAlarming electrocardiogram features in athletes.mp4\u003c\/li\u003e\n\u003cli\u003eAlarming electrocardiogram features in athletes.pdf\u003c\/li\u003e\n\u003cli\u003eAlgorithms for selecting the most appropriate therapy.mp4\u003c\/li\u003e\n\u003cli\u003eAlgorithms for selecting the most appropriate therapy.pdf\u003c\/li\u003e\n\u003cli\u003eAlgorithms to increase CRT effectiveness.mp4\u003c\/li\u003e\n\u003cli\u003eAlgorithms to increase CRT effectiveness.pdf\u003c\/li\u003e\n\u003cli\u003eAlternative solution to CRT – His bundle pacing is my preferrred alternative.mp4\u003c\/li\u003e\n\u003cli\u003eAlternative solution to CRT – His bundle pacing is my preferrred alternative.pdf\u003c\/li\u003e\n\u003cli\u003ealways endocardial first.mp4\u003c\/li\u003e\n\u003cli\u003ealways endocardial first.pdf\u003c\/li\u003e\n\u003cli\u003eAmplified p-wave duration identifies patients at risk for left atrial thrombus formation.pdf\u003c\/li\u003e\n\u003cli\u003eAmplified sinus p-wave duration in early persistent atrial fibrillation.pdf\u003c\/li\u003e\n\u003cli\u003eAn N- L-type calcium channel blocker, cilnidipine, reduces electrical and structural atrial remodeling associated.pdf\u003c\/li\u003e\n\u003cli\u003eAn open invitation for science.mp4\u003c\/li\u003e\n\u003cli\u003eAn open invitation for science.pdf\u003c\/li\u003e\n\u003cli\u003eAnalysis of amplified sinus-p-wave to localise left atrial low voltage substrate and guide pulmonary vein isolation.mp4\u003c\/li\u003e\n\u003cli\u003eAnalysis of amplified sinus-p-wave to localise left atrial low voltage substrate and guide pulmonary vein isolation.pdf\u003c\/li\u003e\n\u003cli\u003eAnatomical characteristics of left superior pulmonary veins which need touch up ablation after hot balloon ablation.pdf\u003c\/li\u003e\n\u003cli\u003eAnatomical considerations for improving safety in the electrophysiology lab.mp4\u003c\/li\u003e\n\u003cli\u003eAnatomical considerations for improving safety in the electrophysiology lab.pdf\u003c\/li\u003e\n\u003cli\u003eAntegrade conduction improvement with fast atrial pacing during radiofrequency ablation of atrioventricular nodal.mp4\u003c\/li\u003e\n\u003cli\u003eAntegrade conduction improvement with fast atrial pacing during radiofrequency ablation of atrioventricular nodal.pdf\u003c\/li\u003e\n\u003cli\u003eAntiarrhythmic action of melatonin is associated with its effects on ventricular spatiotemporal depolarization pattern.pdf\u003c\/li\u003e\n\u003cli\u003eAnticoagulation and CHA2DS2-VASc score of 1 – CONTRA.mp4\u003c\/li\u003e\n\u003cli\u003eAnticoagulation and CHA2DS2-VASc score of 1 – CONTRA.pdf\u003c\/li\u003e\n\u003cli\u003eAnticoagulation and CHA2DS2-VASc score of 1 – PRO.mp4\u003c\/li\u003e\n\u003cli\u003eAnticoagulation and CHA2DS2-VASc score of 1 – PRO.pdf\u003c\/li\u003e\n\u003cli\u003eAntithrombotic therapy in atrial fibrillation associated with acute coronary syndrome and or PCI.mp4\u003c\/li\u003e\n\u003cli\u003eAntithrombotic therapy in atrial fibrillation associated with acute coronary syndrome and or PCI.pdf\u003c\/li\u003e\n\u003cli\u003eAortic pulse wave velocity assessment during atrial fibrillation.pdf\u003c\/li\u003e\n\u003cli\u003eApproach to mapping and ablation of focal atrial tachycardia.mp4\u003c\/li\u003e\n\u003cli\u003eApproach to mapping and ablation of focal atrial tachycardia.pdf\u003c\/li\u003e\n\u003cli\u003eApproaches to difficul supra ventricular tachycardia ablation.mp4\u003c\/li\u003e\n\u003cli\u003eApproaches to difficul supra ventricular tachycardia ablation.pdf\u003c\/li\u003e\n\u003cli\u003eAre the results of the CASTLE-AF trial reproducible in the real life.pdf\u003c\/li\u003e\n\u003cli\u003eAre the risk factors different in pocket- and systemic device infections.pdf\u003c\/li\u003e\n\u003cli\u003eArrhythmia management and device therapies in endocrine disorders.mp4\u003c\/li\u003e\n\u003cli\u003eArrhythmia management and device therapies in endocrine disorders.pdf\u003c\/li\u003e\n\u003cli\u003eArrhythmias from the right and left papillary muscle.mp4\u003c\/li\u003e\n\u003cli\u003eArrhythmias from the right and left papillary muscle.pdf\u003c\/li\u003e\n\u003cli\u003eArrhythmias in children with single ventricle.pdf\u003c\/li\u003e\n\u003cli\u003eArrhythmias in elderly and frailty syndrome.mp4\u003c\/li\u003e\n\u003cli\u003eArrhythmias in elderly and frailty syndrome.pdf\u003c\/li\u003e\n\u003cli\u003eArrhythmias in emergency presentations and acute revascularisation.mp4\u003c\/li\u003e\n\u003cli\u003eArrhythmias in emergency presentations and acute revascularisation.pdf\u003c\/li\u003e\n\u003cli\u003eArrhythmias in pregnancy.mp4\u003c\/li\u003e\n\u003cli\u003eArrhythmias in pregnancy.pdf\u003c\/li\u003e\n\u003cli\u003eArtificial neural network as a predictive instrument of hemorrhagic complications in patients undergoing pacemaker.pdf\u003c\/li\u003e\n\u003cli\u003eARVC and sports.mp4\u003c\/li\u003e\n\u003cli\u003eARVC and sports.pdf\u003c\/li\u003e\n\u003cli\u003eAspects of oestrogen action on cardiomyocyte calcium homeostasis.pdf\u003c\/li\u003e\n\u003cli\u003eAssessment of autonomic nerve modulation after cryoballoon pulmonary vein isolation in patients with paroxysmal.pdf\u003c\/li\u003e\n\u003cli\u003eAssessment of gastrointestinal symptoms in patients undergoing pulmonary vein isolation.pdf\u003c\/li\u003e\n\u003cli\u003eAssessment of myocardial electrical dysynchrony by noninvasive activation mapping and its role in achieving.pdf\u003c\/li\u003e\n\u003cli\u003eAssessment of origin of atrial ectopy on continuous 24-hour holter monitoring in patients with atrial septal defects.pdf\u003c\/li\u003e\n\u003cli\u003eAssessment of scar formation after cryoballon pulmonary vein isolation by 3d left atrial late gadolinium enhancement.pdf\u003c\/li\u003e\n\u003cli\u003eAssessment of the safety and performance of a novel RF balloon catheter system to isolate pulmonary veins.mp4\u003c\/li\u003e\n\u003cli\u003eAssessment of the safety and performance of a novel RF balloon catheter system to isolate pulmonary veins.pdf\u003c\/li\u003e\n\u003cli\u003eAssociation between acute hepatitis B flare and Long-term Clinical Outcomes in patients with Atrial Fibrillation.pdf\u003c\/li\u003e\n\u003cli\u003eAssociation between acute hepatitis C flare and long-term clinical outcomes in patients with atrial fibrillation.pdf\u003c\/li\u003e\n\u003cli\u003eAssociation between biomarkers and atrial fibrillation in patients undergoing implantation of a dual chamber pacemaker.pdf\u003c\/li\u003e\n\u003cli\u003eAssociation between QRS shortening and mortality after implantation of cardiac resynchronization therapy.mp4\u003c\/li\u003e\n\u003cli\u003eAssociation between QRS shortening and mortality after implantation of cardiac resynchronization therapy.pdf\u003c\/li\u003e\n\u003cli\u003eAssociation of late gadolinium enhancement in cardiac magnetic resonance and alterations such as arrhythmias.pdf\u003c\/li\u003e\n\u003cli\u003eAsymptomatic cardiac arrhythmias – Approach, evaluation, consequences and management.mp4\u003c\/li\u003e\n\u003cli\u003eAsymptomatic cardiac arrhythmias – Approach, evaluation, consequences and management.pdf\u003c\/li\u003e\n\u003cli\u003eAsymptomatic Wolff-Parkinson-White syndrome – When not to ablate.mp4\u003c\/li\u003e\n\u003cli\u003eAsymptomatic Wolff-Parkinson-White syndrome – When not to ablate.pdf\u003c\/li\u003e\n\u003cli\u003eAtrial conduction velocity, and novel fibrillation indices shannon entropy and magnitude squared coherence.pdf\u003c\/li\u003e\n\u003cli\u003eAtrial fibrillation – Treat before CRT implantation.mp4\u003c\/li\u003e\n\u003cli\u003eAtrial fibrillation – Treat before CRT implantation.pdf\u003c\/li\u003e\n\u003cli\u003eAtrial fibrillation ablation in heart failure patients PVI-only strategy improves left ventricular systolic function.pdf\u003c\/li\u003e\n\u003cli\u003eAtrial fibrillation ablation.mp4\u003c\/li\u003e\n\u003cli\u003eAtrial fibrillation ablation.pdf\u003c\/li\u003e\n\u003cli\u003eAtrial fibrillation and heart failure – Current knowledge.mp4\u003c\/li\u003e\n\u003cli\u003eAtrial fibrillation and heart failure – Current knowledge.pdf\u003c\/li\u003e\n\u003cli\u003eAtrial fibrillation and outcomes in patients with acute ischemic stroke treated with thrombolysis.pdf\u003c\/li\u003e\n\u003cli\u003eAtrial fibrillation and percutaneous coronary intervention or acute coronary syndrome – Dual or triple therapy.mp4\u003c\/li\u003e\n\u003cli\u003eAtrial fibrillation and percutaneous coronary intervention or acute coronary syndrome – Dual or triple therapy.pdf\u003c\/li\u003e\n\u003cli\u003eAtrial fibrillation and sport.mp4\u003c\/li\u003e\n\u003cli\u003eAtrial fibrillation and sport.pdf\u003c\/li\u003e\n\u003cli\u003eAtrial fibrillation catheter ablation improves the cognitive function.pdf\u003c\/li\u003e\n\u003cli\u003eAtrial fibrillation during chemotherapy – Assessing the risk-benefit ratio for anticoagulation.mp4\u003c\/li\u003e\n\u003cli\u003eAtrial fibrillation during chemotherapy – Assessing the risk-benefit ratio for anticoagulation.pdf\u003c\/li\u003e\n\u003cli\u003eAtrial fibrillation following coronary artery bypass grafting – the role of a preexisting pro-arrhythmic atrial remodeling.pdf\u003c\/li\u003e\n\u003cli\u003eAtrial fibrillation in arrhythmogenic right ventricular cardiomyopathy and its association with ventricular arrhythmias.pdf\u003c\/li\u003e\n\u003cli\u003eAtrial fibrillation in the presence or absence of heart failure is associated with differential expression of genes.pdf\u003c\/li\u003e\n\u003cli\u003eAtrial fibrillation is an independent predictor of falls risk, syncope \u0026amp; orthostatic intolerance in older adults.pdf\u003c\/li\u003e\n\u003cli\u003eAtrial fibrillation type and renal dysfunction as important predictors of left atrial thrombus in atrial fibrillation.pdf\u003c\/li\u003e\n\u003cli\u003eAtrial high rates episodes predict the development of heart failure with preserved ejection fraction.pdf\u003c\/li\u003e\n\u003cli\u003eAtrial remodeling in heart failure with and without preserved ejection fraction.mp4\u003c\/li\u003e\n\u003cli\u003eAtrial remodeling in heart failure with and without preserved ejection fraction.pdf\u003c\/li\u003e\n\u003cli\u003eAtrial tachycardia localisation based on the P wave.mp4\u003c\/li\u003e\n\u003cli\u003eAtrial tachycardia localisation based on the P wave.pdf\u003c\/li\u003e\n\u003cli\u003eAtrioventricular block with transcatheter aortic valve implantation is it still a problem.mp4\u003c\/li\u003e\n\u003cli\u003eAtrioventricular block with transcatheter aortic valve implantation is it still a problem.pdf\u003c\/li\u003e\n\u003cli\u003eAtypical forms of AVNRT are more prevalent in athletes.pdf\u003c\/li\u003e\n\u003cli\u003eAutomap utilization and threshold settings for mapping persistent atrial fibrillation using a high-density grid-style catheter.pdf\u003c\/li\u003e\n\u003cli\u003eAutomated measure of right atrial electrogram complexity predicts acute outcome of extra-pulmonary vein.pdf\u003c\/li\u003e\n\u003cli\u003eAutomatic data transfer from programmers and web-based platforms to electronic health records.mp4\u003c\/li\u003e\n\u003cli\u003eAutomatic data transfer from programmers and web-based platforms to electronic health records.pdf\u003c\/li\u003e\n\u003cli\u003eAutomatic identification and reconstruction of the right phrenic nerve on computed tomography.pdf\u003c\/li\u003e\n\u003cli\u003eAutomatic non-invasive substrate analysis from CT images in post-infarction VT.pdf\u003c\/li\u003e\n\u003cli\u003eAutomatic pacing output failure as a cause of repeated syncope.pdf\u003c\/li\u003e\n\u003cli\u003eAwareness of alarming symptoms just before cardiac arrest – Can we learn from ESCAPE-NET.mp4\u003c\/li\u003e\n\u003cli\u003eAwareness of alarming symptoms just before cardiac arrest – Can we learn from ESCAPE-NET.pdf\u003c\/li\u003e\n\u003cli\u003eBalloon technologies.mp4\u003c\/li\u003e\n\u003cli\u003eBalloon technologies.pdf\u003c\/li\u003e\n\u003cli\u003eBasic science.mp4\u003c\/li\u003e\n\u003cli\u003eBasic science.pdf\u003c\/li\u003e\n\u003cli\u003ebefore the second episode – Don’t wait for recurrences.mp4\u003c\/li\u003e\n\u003cli\u003ebefore the second episode – Don’t wait for recurrences.pdf\u003c\/li\u003e\n\u003cli\u003eBelieve in a second chance for Atrial Fibrillation.mp4\u003c\/li\u003e\n\u003cli\u003eBiatrial pacing using a canted left ventricular lead in the distal coronary sinus one-year results from a series of six cases.pdf\u003c\/li\u003e\n\u003cli\u003eBiomarkers in atrial fibrillation novel red flags to keep in mind.pdf\u003c\/li\u003e\n\u003cli\u003eBipolar radiofrequency ablation of parahisian premature ventricular contractions.pdf\u003c\/li\u003e\n\u003cli\u003eBlanking period following ablation fake news.mp4\u003c\/li\u003e\n\u003cli\u003eBlanking period following ablation fake news.pdf\u003c\/li\u003e\n\u003cli\u003eBlockade of the adenosine 2A receptor mitigates the cardiomyopathy induced by loss of plakophilin-2 expression.pdf\u003c\/li\u003e\n\u003cli\u003eBroad QRS tachycardias – Part 1.mp4\u003c\/li\u003e\n\u003cli\u003eBroad QRS tachycardias – Part 1.pdf\u003c\/li\u003e\n\u003cli\u003eBroad QRS tachycardias – Part 2.mp4\u003c\/li\u003e\n\u003cli\u003eBroad QRS tachycardias – Part 2.pdf\u003c\/li\u003e\n\u003cli\u003eBrugada syndrome – New insight from genetic studies.mp4\u003c\/li\u003e\n\u003cli\u003eBrugada syndrome – New insight from genetic studies.pdf\u003c\/li\u003e\n\u003cli\u003eBrugada syndrome in a young patient with type 1 myotonic dystrophy requiring an implantable cardioverter.pdf\u003c\/li\u003e\n\u003cli\u003eBrugada syndrome.mp4\u003c\/li\u003e\n\u003cli\u003eBrugada syndrome.pdf\u003c\/li\u003e\n\u003cli\u003eBuilding an EU-funded network for sudden cardiac arrest research – ESCAPE-NET.mp4\u003c\/li\u003e\n\u003cli\u003eBuilding an EU-funded network for sudden cardiac arrest research – ESCAPE-NET.pdf\u003c\/li\u003e\n\u003cli\u003eBurden of atrial ectopy after pulmonary vein isolation is a predictor of procedural success.pdf\u003c\/li\u003e\n\u003cli\u003eCABANA will affect my clinical decision making in atrial fibrillation ablation – CONTRA.mp4\u003c\/li\u003e\n\u003cli\u003eCABANA will affect my clinical decision making in atrial fibrillation ablation – CONTRA.pdf\u003c\/li\u003e\n\u003cli\u003eCABANA will affect my clinical decision making in atrial fibrillation ablation – PRO.mp4\u003c\/li\u003e\n\u003cli\u003eCABANA will affect my clinical decision making in atrial fibrillation ablation – PRO.pdf\u003c\/li\u003e\n\u003cli\u003eCalmodulin mutations and channel dysfunction knowns and unknowns.mp4\u003c\/li\u003e\n\u003cli\u003eCalmodulin mutations and channel dysfunction knowns and unknowns.pdf\u003c\/li\u003e\n\u003cli\u003eCan the local electrogram amplitude using the 8mm tip catheter with mini electrodes predict the successful.pdf\u003c\/li\u003e\n\u003cli\u003eCardiac imaging for planning redo cases.mp4\u003c\/li\u003e\n\u003cli\u003eCardiac imaging for planning redo cases.pdf\u003c\/li\u003e\n\u003cli\u003eCardiac MRI evaluation of right and left atrial fibrosis in patients with atrial septal defects.pdf\u003c\/li\u003e\n\u003cli\u003eCardiac resynchronization theraphy in non-ambulatory nyha class four heart failure patients.pdf\u003c\/li\u003e\n\u003cli\u003eCardiac resynchronization therapy in primary prevention patients do we need to shock.pdf\u003c\/li\u003e\n\u003cli\u003eCardiovascular neurohormones impact time to onset of vasovagal syncope induced by head-up tilt.pdf\u003c\/li\u003e\n\u003cli\u003eCatecholaminergic polymorphic centricular tachycardia.mp4\u003c\/li\u003e\n\u003cli\u003eCatecholaminergic polymorphic centricular tachycardia.pdf\u003c\/li\u003e\n\u003cli\u003eCatheter ablation for short-coupled Torsade de Pointes.mp4\u003c\/li\u003e\n\u003cli\u003eCatheter ablation for short-coupled Torsade de Pointes.pdf\u003c\/li\u003e\n\u003cli\u003eCatheter ablation of atrial fibrillation in patients with heart failure with reduced and preserved systolic function.pdf\u003c\/li\u003e\n\u003cli\u003eCatheter ablation of atypical atrial flutter using high-density three-dimensional mapping systems.pdf\u003c\/li\u003e\n\u003cli\u003eCatheter ablation of atypical atrioventricular nodal reentry tachycardia.mp4\u003c\/li\u003e\n\u003cli\u003eCatheter ablation of atypical atrioventricular nodal reentry tachycardia.pdf\u003c\/li\u003e\n\u003cli\u003eCatheter ablation of left-sided accessory pathways in small children.pdf\u003c\/li\u003e\n\u003cli\u003eCatheter ablation of nonparoxysmal atrial fibrillation using electrophysiologically guided adjunctive left atrial.pdf\u003c\/li\u003e\n\u003cli\u003eCatheter ablation versus medical therapy for treatment of symptomatic frequent ventricular premature complexes.mp4\u003c\/li\u003e\n\u003cli\u003eCatheter ablation versus medical therapy for treatment of symptomatic frequent ventricular premature complexes.pdf\u003c\/li\u003e\n\u003cli\u003eCatheter ablation versus medical therapy for treatment of ventricular tachycardia associated with structural.pdf\u003c\/li\u003e\n\u003cli\u003eCatheters, sub-selectors and leads.mp4\u003c\/li\u003e\n\u003cli\u003eCatheters, sub-selectors and leads.pdf\u003c\/li\u003e\n\u003cli\u003eCauses and prognosis of incidental left bundle branch block.pdf\u003c\/li\u003e\n\u003cli\u003eChagas disease.mp4\u003c\/li\u003e\n\u003cli\u003eChagas disease.pdf\u003c\/li\u003e\n\u003cli\u003eChairperson conclusion \u0026amp; closing question – Addressing unknowns in CRT -1.mp4\u003c\/li\u003e\n\u003cli\u003eChairperson conclusion \u0026amp; closing question – Addressing unknowns in CRT -1.pdf\u003c\/li\u003e\n\u003cli\u003eChairperson conclusion \u0026amp; closing question – Addressing unknowns in CRT -2.mp4\u003c\/li\u003e\n\u003cli\u003eChairperson conclusion \u0026amp; closing question – Addressing unknowns in CRT -2.pdf\u003c\/li\u003e\n\u003cli\u003eChairperson conclusion \u0026amp; closing question – Controversies in atrial fibrillation ablation -1.mp4\u003c\/li\u003e\n\u003cli\u003eChairperson conclusion \u0026amp; closing question – Controversies in atrial fibrillation ablation -1.pdf\u003c\/li\u003e\n\u003cli\u003eChairperson conclusion \u0026amp; closing question – Controversies in atrial fibrillation ablation -2.mp4\u003c\/li\u003e\n\u003cli\u003eChairperson conclusion \u0026amp; closing question – Controversies in atrial fibrillation ablation -2.pdf\u003c\/li\u003e\n\u003cli\u003eChairperson conclusion \u0026amp; closing question – Knowledge gaps in clinical atrial fibrillation -1.mp4\u003c\/li\u003e\n\u003cli\u003eChairperson conclusion \u0026amp; closing question – Knowledge gaps in clinical atrial fibrillation -1.pdf\u003c\/li\u003e\n\u003cli\u003eChairperson conclusion \u0026amp; closing question – Knowledge gaps in clinical atrial fibrillation -2.mp4\u003c\/li\u003e\n\u003cli\u003eChairperson conclusion \u0026amp; closing question – Knowledge gaps in clinical atrial fibrillation -2.pdf\u003c\/li\u003e\n\u003cli\u003eChairperson conclusion \u0026amp; closing question – Ventricular tachycardia ablation in ischaemic cardiomyopathy -1.mp4\u003c\/li\u003e\n\u003cli\u003eChairperson conclusion \u0026amp; closing question – Ventricular tachycardia ablation in ischaemic cardiomyopathy -1.pdf\u003c\/li\u003e\n\u003cli\u003eChairperson conclusion \u0026amp; closing question – Ventricular tachycardia ablation in ischaemic cardiomyopathy -2.mp4\u003c\/li\u003e\n\u003cli\u003eChairperson conclusion \u0026amp; closing question – Ventricular tachycardia ablation in ischaemic cardiomyopathy -2.pdf\u003c\/li\u003e\n\u003cli\u003eChallenges in epicardial access – Adhesions, bypass grafts and others.mp4\u003c\/li\u003e\n\u003cli\u003eChallenges in epicardial access – Adhesions, bypass grafts and others.pdf\u003c\/li\u003e\n\u003cli\u003eChallenging accessory pathways.mp4\u003c\/li\u003e\n\u003cli\u003eChallenging accessory pathways.pdf\u003c\/li\u003e\n\u003cli\u003eChallenging premature ventricular contractions sites in patients with systolic dysfunction.mp4\u003c\/li\u003e\n\u003cli\u003eChallenging premature ventricular contractions sites in patients with systolic dysfunction.pdf\u003c\/li\u003e\n\u003cli\u003eChanges to the EHRA Constitution.mp4\u003c\/li\u003e\n\u003cli\u003eChanges to the EHRA Constitution.pdf\u003c\/li\u003e\n\u003cli\u003eChanging of delta-wave polarity during 24-hour ecg monitoring in patients with wpw syndrome as a predictor of presense.pdf\u003c\/li\u003e\n\u003cli\u003eChannelopathies and sports.mp4\u003c\/li\u003e\n\u003cli\u003eChannelopathies and sports.pdf\u003c\/li\u003e\n\u003cli\u003eCharacterisation of sudden death circumstances in young adults. Insights from a 6-year web-based Italian study.pdf\u003c\/li\u003e\n\u003cli\u003eCharacterisation of the arrhythmia substrate in patients with atrial septal defects.pdf\u003c\/li\u003e\n\u003cli\u003eCharacteristics of non-pulmonary vein foci induced after 2nd-generation cryoballoon pulmonary vein isolation.pdf\u003c\/li\u003e\n\u003cli\u003eCharacterization of right ventricular electromechanical tissue substrates in arrhythmogenic cardiomyopathy.mp4\u003c\/li\u003e\n\u003cli\u003eCharacterization of right ventricular electromechanical tissue substrates in arrhythmogenic cardiomyopathy.pdf\u003c\/li\u003e\n\u003cli\u003eChronic if current blockade prevents heart rate lowering during acute vagal stimulation.pdf\u003c\/li\u003e\n\u003cli\u003eCIEDs and sports – Special considerations.mp4\u003c\/li\u003e\n\u003cli\u003eCIEDs and sports – Special considerations.pdf\u003c\/li\u003e\n\u003cli\u003eCIRCA-DOSE Study – Discussion.mp4\u003c\/li\u003e\n\u003cli\u003eCIRCA-DOSE Study – Discussion.pdf\u003c\/li\u003e\n\u003cli\u003eClinical and electrocardiographic features of arrhythmogenic right ventricular cardiomyopathy in children.pdf\u003c\/li\u003e\n\u003cli\u003eClinical atrial fibrillation.mp4\u003c\/li\u003e\n\u003cli\u003eClinical atrial fibrillation.pdf\u003c\/li\u003e\n\u003cli\u003eClinical benefit from ultrasound-guided femoral venipuncture for catheter ablation of atrial fibrillation.pdf\u003c\/li\u003e\n\u003cli\u003eClinical features, predictors, and long-term prognosis of pacing-induced cardiomyopathy.pdf\u003c\/li\u003e\n\u003cli\u003eClinical impact of adherence to non-vitamin k antagonist oral anticoagulants in real-world patients with atrial fibrillation.pdf\u003c\/li\u003e\n\u003cli\u003eClinical outcome of cardiac resynchronization therapy in patients randomized to an active fixation bipolar.pdf\u003c\/li\u003e\n\u003cli\u003eClinical outcome of the 2nd generation cryoballoon for pulmonary vein isolation in patients with persistent.pdf\u003c\/li\u003e\n\u003cli\u003eClinical outcomes after catheter ablation for atrial fibrillation in elderly patients a French nationwide cohort study.pdf\u003c\/li\u003e\n\u003cli\u003eClinical outcomes of stereotactic radio-ablation for the management of refractory ventricular tachycardia.pdf\u003c\/li\u003e\n\u003cli\u003eClosing remarks.mp4\u003c\/li\u003e\n\u003cli\u003eCoagulation cascade, inflammatory and fibrosis markers in patients with paroxysmal persistent atrial fibrillation.pdf\u003c\/li\u003e\n\u003cli\u003eComparing multiple mapping methods at sites where persistent AF terminates the COMPARE-AF registry.mp4\u003c\/li\u003e\n\u003cli\u003eComparing multiple mapping methods at sites where persistent AF terminates the COMPARE-AF registry.pdf\u003c\/li\u003e\n\u003cli\u003eComparison between contact force monitoring and unipolar signal modification as a guide for catheter ablation.mp4\u003c\/li\u003e\n\u003cli\u003eComparison between contact force monitoring and unipolar signal modification as a guide for catheter ablation.pdf\u003c\/li\u003e\n\u003cli\u003eComparison of ischemic stroke risk in atrial fibrillation patients with or without myocardial infarction.pdf\u003c\/li\u003e\n\u003cli\u003eComparison of right and left atrial parameters analysed by cardiac magnetic resonance in patients with atrial fibrillation.pdf\u003c\/li\u003e\n\u003cli\u003eComparison of two types of rotational mechanical dilatator sheath.pdf\u003c\/li\u003e\n\u003cli\u003eComparisons between novel and standard high-density 3D mapping systems for ablation of atrial tachycardia.pdf\u003c\/li\u003e\n\u003cli\u003eComplex atrial arrhythmias are we closer to find the way to success.pdf\u003c\/li\u003e\n\u003cli\u003eComplications of radiofrequency ablation in children.pdf\u003c\/li\u003e\n\u003cli\u003eComplications related to elective generator replacement of the subcutaneous implantable defibrillator.pdf\u003c\/li\u003e\n\u003cli\u003eComputed tomography guided risk stratification for lead extraction.pdf\u003c\/li\u003e\n\u003cli\u003eConclusion Advanced technologies for personalised disease management.mp4\u003c\/li\u003e\n\u003cli\u003eConclusions – The growing prevalence of Atrial Fibrilation (AF) the need for devices that detect, reduce and respond to AF.mp4\u003c\/li\u003e\n\u003cli\u003eConclusions – The growing prevalence of Atrial Fibrilation (AF) the need for devices that detect, reduce and respond to AF.pdf\u003c\/li\u003e\n\u003cli\u003eConcomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation.pdf\u003c\/li\u003e\n\u003cli\u003eConcomitant genetic ablation of L-type Cav1.3 and T-type Cav3.1 Ca2+ channels disrupts heart automaticity.mp4\u003c\/li\u003e\n\u003cli\u003eConcomitant genetic ablation of L-type Cav1.3 and T-type Cav3.1 Ca2+ channels disrupts heart automaticity.pdf\u003c\/li\u003e\n\u003cli\u003eContexts associated with difficult cavo-tricuspid isthmus ablation.mp4\u003c\/li\u003e\n\u003cli\u003eContexts associated with difficult cavo-tricuspid isthmus ablation.pdf\u003c\/li\u003e\n\u003cli\u003eContinuous monitoring leads to the new diagnosis of AF in the majority of patients after ablation of typical flutter.pdf\u003c\/li\u003e\n\u003cli\u003eConventional single lead ventricular pacemaker against leadless pacemaker system in real-world patients.pdf\u003c\/li\u003e\n\u003cli\u003eCorrelation of left atrial low voltage and fractionation substrate between sinus rhythm and atrial fibrillation.pdf\u003c\/li\u003e\n\u003cli\u003eCorrelations between voltage map and p wave duration in patients with bayes syndrome undergoing catheter ablation.pdf\u003c\/li\u003e\n\u003cli\u003eCould fragmented QRS predict mortality in aortic stenosis patients after transcatheter aortic valve implantation.pdf\u003cbr\u003e\nCRT implantation in patients with moderate-to-severe renal dysfunction results from the CRT-MORE registry.pdf\u003cbr\u003e\nCRT in a patient that did benefit and one that did not why.mp4\u003cbr\u003e\nCRT in a patient that did benefit and one that did not why.pdf\u003cbr\u003e\nCryoablation for persistent and long standing persistent atrial fibrillation results from a multicentre european registry.pdf\u003cbr\u003e\nCryoablation of septal accessory pathways a single center experience.pdf\u003cbr\u003e\nCryoballoon ablation of atrial fibrillation in 4 patients with atrial septal occluder.pdf\u003cbr\u003e\nCryoballoon pulmonary vein isolation is effective in both paroxysmal and persistent atrial fibrillation.pdf\u003cbr\u003e\nCryobaloon pulmonary veins isolation in atrial fibrillation treatment additionally restores repolarization pattern.pdf\u003cbr\u003e\nCurrent indications.mp4\u003cbr\u003e\nCurrent indications.pdf\u003cbr\u003e\nCurrent status of cardiac imaging.mp4\u003cbr\u003e\nCurrent status of cardiac imaging.pdf\u003cbr\u003e\nCurrent use of CRT in patients with atrial fibrillation – Data from the ESC EHRA HFA Survey II.pdf\u003cbr\u003e\nCybersecurity – How big is the threat and how to be safe.mp4\u003cbr\u003e\nCybersecurity – How big is the threat and how to be safe.pdf\u003cbr\u003e\nDay case complex devices – The state of the UK.pdf\u003cbr\u003e\nDealing with consent and data protection – Responsibilities and liabilities.mp4\u003cbr\u003e\nDealing with consent and data protection – Responsibilities and liabilities.pdf\u003cbr\u003e\nDefinition and classification of syncopal and non-syncopal forms of transient loss of consciousness.mp4\u003cbr\u003e\nDefinition and classification of syncopal and non-syncopal forms of transient loss of consciousness.pdf\u003cbr\u003e\nDemographics and clinical characteristics of patients newly diagnosed with paroxysmal supraventricular tachycardia.pdf\u003cbr\u003e\nDepression and anxiety during the first 12 months post-implant.mp4\u003cbr\u003e\nDepression and anxiety during the first 12 months post-implant.pdf\u003cbr\u003e\nDetect how important is early and accurate detection of AF (1).mp4\u003cbr\u003e\nDetect how important is early and accurate detection of AF.mp4\u003cbr\u003e\nDetect how important is early and accurate detection of AF.pdf\u003cbr\u003e\nDeterminants of battery longevity of internal cardioverter defibrillators with and without cardiac resynchronization.pdf\u003cbr\u003e\nDetermining the diagnostic yield for atrial fibrillation using continuous smartwatch monitoring.pdf\u003cbr\u003e\nDevelopment and validation of a new ECG algorithm to diagnose the origin of endocardial outflow tract ventricular.pdf\u003cbr\u003e\nDevelopment of a prognostic model for recurrent atrial fibrillation using individual patient data from 2429 patients with AF.pdf\u003cbr\u003e\nDevice implanted patients – Part 1.mp4\u003cbr\u003e\nDevice implanted patients – Part 1.pdf\u003cbr\u003e\nDevice implanted patients – Part 2.mp4\u003cbr\u003e\nDevice implanted patients – Part 2.pdf\u003cbr\u003e\nDevice replacement strategy in CRT-D patients interim results of the BioCONTINUE study.pdf\u003cbr\u003e\nDiabetes mellitus, time in the therapeutic range and adverse outcomes in patients with atrial fibrillation.pdf\u003cbr\u003e\nDiagnostic and prognostic value of the QRS-T angle in patients with suspected acute decompensated heart failure.pdf\u003cbr\u003e\nDiagnostic power of computed tomography for left atrial appendage thrombus in patients anticoagulated.pdf\u003cbr\u003e\nDifference of symptom characteristics of atrial fibrillation in patients with concomitant left ventricular dysfunction.pdf\u003cbr\u003e\nDifferent risk of new-onset atrial fibrillation on patients with primary aldosteronism after surgical or medical treatment.pdf\u003cbr\u003e\nDifferent techniques of cardiac leads extraction 17-years single centre experience.pdf\u003cbr\u003e\nDifferentiating the exercise-induced effects of acute beta-adrenergic stimulation and stretch on calcium.mp4\u003cbr\u003e\nDifferentiating the exercise-induced effects of acute beta-adrenergic stimulation and stretch on calcium.pdf\u003cbr\u003e\nDifficult atrioventricular nodal reentry tachycardia.mp4\u003cbr\u003e\nDifficult atrioventricular nodal reentry tachycardia.pdf\u003cbr\u003e\nDifficult routes to the heart.mp4\u003cbr\u003e\nDifficult routes to the heart.pdf\u003cbr\u003e\nDirect Validation Electrocardiography Imaging (ECGi) by Epicardial Contact Mapping during VT Ablation.mp4\u003cbr\u003e\nDirect Validation Electrocardiography Imaging (ECGi) by Epicardial Contact Mapping during VT Ablation.pdf\u003cbr\u003e\nDisease management by remote monitoring – A must-have. You will see wonders.mp4\u003cbr\u003e\nDisease management by remote monitoring – A must-have. You will see wonders.pdf\u003cbr\u003e\nDisease management by remote monitoring – Nice to have but don’t expect wonders.mp4\u003cbr\u003e\nDisease management by remote monitoring – Nice to have but don’t expect wonders.pdf\u003cbr\u003e\nDistilling the clinical evidence behind the WCD – What have clinical trials and registries told us.mp4\u003cbr\u003e\nDistilling the clinical evidence behind the WCD – What have clinical trials and registries told us.pdf\u003cbr\u003e\nDistinguishing typical from atypical flutter on the ECG.mp4\u003cbr\u003e\nDistinguishing typical from atypical flutter on the ECG.pdf\u003cbr\u003e\nDistribution of reablated antral segments after initial pulmonary vein isolation with use of ablation index.pdf\u003cbr\u003e\nDo DDD pacemakers increase the incidence of atrial fibrillation.pdf\u003cbr\u003e\nDoes carto visitag size (2 mm vs 3 mm) using the ablation index modify immediate procedural outcome in circumferencial.pdf\u003cbr\u003e\nDoes ventricular tachycardia ablation impact ventricular fibrillation occurence.mp4\u003cbr\u003e\nDoes ventricular tachycardia ablation impact ventricular fibrillation occurence.pdf\u003cbr\u003e\nDriving minimal ablation in ultra high-density atrial mapping with local impedance.mp4\u003cbr\u003e\nDriving minimal ablation in ultra high-density atrial mapping with local impedance.pdf\u003cbr\u003e\nDriving restrictions.mp4\u003cbr\u003e\nDriving restrictions.pdf\u003cbr\u003e\nDynamic high density mapping of late potentials and late repolarization identifies critical sites for ablation.mp4\u003cbr\u003e\nDynamic high density mapping of late potentials and late repolarization identifies critical sites for ablation.pdf\u003cbr\u003e\nEarly outcomes of radiosurgery for refractory ventricular tachycardia using the CyberHeart planning system.mp4\u003cbr\u003e\nEarly outcomes of radiosurgery for refractory ventricular tachycardia using the CyberHeart planning system.pdf\u003cbr\u003e\nECG localisation of accessory pathways.mp4\u003cbr\u003e\nECG localisation of accessory pathways.pdf\u003cbr\u003e\nECG T-wave predictors of Ajmaline Positivity and Arrhtyhmic Risk In Ajmaline Positive Patients.pdf\u003cbr\u003e\nECG, rhythm diagnostics \u0026amp; syncope.mp4\u003cbr\u003e\nECG, rhythm diagnostics \u0026amp; syncope.pdf\u003cbr\u003e\nEcho-endoscopic evaluation of the esophagus after enclosing the pulmonary veins with contiguous and optimized RF lesions.pdf\u003cbr\u003e\nEchocardiography. Does it still play a role.mp4\u003cbr\u003e\nEchocardiography. Does it still play a role.pdf\u003cbr\u003e\nEffect of activation wavefront on electrogram characteristics during ventricular tachycardia ablation.mp4\u003cbr\u003e\nEffect of activation wavefront on electrogram characteristics during ventricular tachycardia ablation.pdf\u003cbr\u003e\nEffect of age on the usability of a photoplethysmography based smartphone application.pdf\u003cbr\u003e\nEffect of atrial fibrillation on cardiac resynchronization therapy in patients with dilated cardiomyopathy.pdf\u003cbr\u003e\nEffect of cardiac resynchronization therapy on ventricular tachycardias in patients with dilated cardiomyopathy.pdf\u003cbr\u003e\nEffect of multipoint adaptive pacing and ventricular fusion on LV dP dtmax in CRT.pdf\u003cbr\u003e\nEfficacy and safety of cryoballoon ablation in heart failure a multicenter study.pdf\u003cbr\u003e\nEHRA EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – An update.mp4\u003cbr\u003e\nEHRA EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – An update.pdf\u003cbr\u003e\nEHRA expert consensus statement on lead extraction.mp4\u003cbr\u003e\nEHRA expert consensus statement on lead extraction.pdf\u003cbr\u003e\nEinthoven Lecture – Electrophysiology in a humanitarian context.mp4\u003cbr\u003e\nEinthoven Lecture – Electrophysiology in a humanitarian context.pdf\u003cbr\u003e\nEinthoven Lecture – Pacing in a humanitarian context.mp4\u003cbr\u003e\nEinthoven Lecture – Pacing in a humanitarian context.pdf\u003cbr\u003e\nElectrical activation versus mechanical contraction in cardiac resynchronization therapy recipients.mp4\u003cbr\u003e\nElectrical activation versus mechanical contraction in cardiac resynchronization therapy recipients.pdf\u003cbr\u003e\nElectrical perfomance and complicationsof leadless pacemakers implantation in elderly patients.pdf\u003cbr\u003e\nElectrical storm – Reprogramming, drugs, ablation, denervation or transplantation.mp4\u003cbr\u003e\nElectrical storm – Reprogramming, drugs, ablation, denervation or transplantation.pdf\u003cbr\u003e\nElectroanatomic and histological right ventricular outflow tract alterations in patients with Brugada syndrome.pdf\u003cbr\u003e\nElectroanatomic reconstruction in pediatric catheter ablations using the CARTO3 mapping system.pdf\u003cbr\u003e\nElectrocardiogram imaging – A nice-to-have or a must-have tool.mp4\u003cbr\u003e\nElectrocardiogram imaging – A nice-to-have or a must-have tool.pdf\u003cbr\u003e\nElectroporation.mp4\u003cbr\u003e\nElectroporation.pdf\u003cbr\u003e\nEligibility and disqualification for competition.mp4\u003cbr\u003e\nEligibility and disqualification for competition.pdf\u003cbr\u003e\nELIMINATE-AF Trial – Discussion.mp4\u003cbr\u003e\nELIMINATE-AF Trial – Discussion.pdf\u003cbr\u003e\nEmbolic stroke of undetermined source (ESUS) – Anticoagulation for everyone or search for atrial fibrillation.mp4\u003cbr\u003e\nEmbolic stroke of undetermined source (ESUS) – Anticoagulation for everyone or search for atrial fibrillation.pdf\u003cbr\u003e\nEMIT AF VTE study – Discussion.mp4\u003cbr\u003e\nEMIT AF VTE study – Discussion.pdf\u003cbr\u003e\nEnabling antitachycardia pacing and pacing in extravascular ICDs.mp4\u003cbr\u003e\nEnabling antitachycardia pacing and pacing in extravascular ICDs.pdf\u003cbr\u003e\nEnd-of-life decisions in ICD carriers – When should ICD therapy be re-considered.mp4\u003cbr\u003e\nEnd-of-life decisions in ICD carriers – When should ICD therapy be re-considered.pdf\u003cbr\u003e\nEndo-epicardial ablation.mp4\u003cbr\u003e\nEndo-epicardial ablation.pdf\u003cbr\u003e\nEndoatrial contact phase mapping in atrial fibrillation using the PentaRay catheter.pdf\u003cbr\u003e\nEndpoints to validate bidirectional block.mp4\u003cbr\u003e\nEndpoints to validate bidirectional block.pdf\u003cbr\u003e\nEpicardial connections between right pulmonary veins and the right atrium. Relevance for effective ablation.pdf\u003cbr\u003e\nEsophageal cooling for prevention of thermal lesions during left atrial ablation procedures first in man case series.pdf\u003cbr\u003e\nEthnical differences in patients with brugada syndrome and arrhythmic events new insights from sabrus.pdf\u003cbr\u003e\nEuroEco (European health economic trial on home monitoring in ICD and CRT-D patients).pdf\u003cbr\u003e\nEuropean experience with a novel high-density grid-style mapping catheter.pdf\u003cbr\u003e\nEvaluating the performance of automatic threshold testing algorithms in the setting of His bundle pacing.pdf\u003cbr\u003e\nEvaluating the risk of rhabdomyolysis and myopathy associated with concomitant use of dronedarone.pdf\u003cbr\u003e\nEvaluation of a new technique aiming at optimizing catheter stability at the anterior portion of the left pulmonary veins.mp4\u003cbr\u003e\nEvaluation of a new technique aiming at optimizing catheter stability at the anterior portion of the left pulmonary veins.pdf\u003cbr\u003e\nEvaluation of arterial baroreflex sensitivity in subjects with postural tachycardia syndrome.pdf\u003cbr\u003e\nEvaluation of modified valsalva maneuver in treatment of supraventricular tachycardia among adult patients.pdf\u003cbr\u003e\nEvaluation of syncope in emergency care units.pdf\u003cbr\u003e\nEvolution and triggers of appropriate ICD shocks in patients with arrhythmogenic cardiomyopathy during long-term follow-up.pdf\u003cbr\u003e\nEvolution of electrocardiographic abnormalities and arrhythmias in adult patients with beta thalassemia major.pdf\u003cbr\u003e\nExtent and spatial distribution of left atrial arrhythmogenic sites, late gadolinium enhancement at MRI.pdf\u003cbr\u003e\nExtracting a leadless pacemaker.mp4\u003cbr\u003e\nExtracting a leadless pacemaker.pdf\u003cbr\u003e\nFavourable long-term results of contact force-controlled robotic-navigated left atrial linear ablation.pdf\u003cbr\u003e\nFeasibility and mid-term outcome of Micra implant after transvenous lead extraction.pdf\u003cbr\u003e\nFeasibility of single position endoscopic laser balloon ablation for atrial fibrillation the open 8 approach.pdf\u003cbr\u003e\nFemale, 80 years with paroxysmal atrial fibrillation and falls.mp4\u003cbr\u003e\nFemale, 80 years with paroxysmal atrial fibrillation and falls.pdf\u003cbr\u003e\nFibrosis and apoptosis in different aetiologies of cardiomyopathy and their role in response to cardiac.pdf\u003cbr\u003e\nFirst clinical use of novel ablation catheter incorporating local impedance data.mp4\u003cbr\u003e\nFirst clinical use of novel ablation catheter incorporating local impedance data.pdf\u003cbr\u003e\nFirst experience of extraction of a quadripolar active fixation left ventricular lead.pdf\u003cbr\u003e\nFirst results of ultra-low cryoablation in patients with cavotricuspid isthmus dependent atrial flutter.mp4\u003cbr\u003e\nFirst results of ultra-low cryoablation in patients with cavotricuspid isthmus dependent atrial flutter.pdf\u003cbr\u003e\nFirst results of ultra-low temperature cryoablation with a single-shot ablation catheter in patients.pdf\u003cbr\u003e\nFit to fly.mp4\u003cbr\u003e\nFit to fly.pdf\u003cbr\u003e\nFor the typical VVIR pacemaker recipient, leadless pacing is just a gimmick.mp4\u003cbr\u003e\nFor the typical VVIR pacemaker recipient, leadless pacing is just a gimmick.pdf\u003cbr\u003e\nForget mapping – Lines and predefined ablation.mp4\u003cbr\u003e\nForget mapping – Lines and predefined ablation.pdf\u003cbr\u003e\nFrailty index or comorbidity index for bleeding risk assessment in patients with atrial fibrillation.pdf\u003cbr\u003e\nFully automated measurements of scar size on computed tomography relate to arrhythmia risk in post-infarction.mp4\u003cbr\u003e\nFully automated measurements of scar size on computed tomography relate to arrhythmia risk in post-infarction.pdf\u003cbr\u003e\nGain-of-function mutation in the cardiac kv4.2 potassium channel underlies paroxysmal atrial fibrillation.mp4\u003cbr\u003e\nGain-of-function mutation in the cardiac kv4.2 potassium channel underlies paroxysmal atrial fibrillation.pdf\u003cbr\u003e\nGalectin-3 as a new thrombotic risk factor in patients with atrial fibrillation.pdf\u003cbr\u003e\nGALLERY – Discussion.mp4\u003cbr\u003e\nGALLERY – Discussion.pdf\u003cbr\u003e\nGap junction modulation is a major determinant of the mechanism and organisation of ventricular fibrillation.pdf\u003cbr\u003e\nGastro-intestinal disorders and arrhythmias.mp4\u003cbr\u003e\nGastro-intestinal disorders and arrhythmias.pdf\u003cbr\u003e\nGene expression changes in a novel mouse model of dyssynchrony and resynchronization in heart failure.pdf\u003cbr\u003e\nGeneration of iPSC from human adult progenitor cells reprogramming efficiency and cardiac differentiation potential.mp4\u003cbr\u003e\nGeneration of iPSC from human adult progenitor cells reprogramming efficiency and cardiac differentiation potential.pdf\u003cbr\u003e\nGenetics in atrial fibrillation.mp4\u003cbr\u003e\nGenetics in atrial fibrillation.pdf\u003cbr\u003e\nGlobe mapping.mp4\u003cbr\u003e\nGlobe mapping.pdf\u003cbr\u003e\nGUCH patients – Many leads and complex anatomies. Balancing the risk of extraction with long-term benefit.mp4\u003cbr\u003e\nGUCH patients – Many leads and complex anatomies. Balancing the risk of extraction with long-term benefit.pdf\u003cbr\u003e\nGuideline-directed therapy at discharge is important in patients with heart failure and atrial fibrillation.pdf\u003cbr\u003e\nHaemodynamically compromising ventricular tachycardia assessed under haemodynamic support depends on functional.mp4\u003cbr\u003e\nHaemodynamically compromising ventricular tachycardia assessed under haemodynamic support depends on functional.pdf\u003cbr\u003e\nHandling of smartphone ECG Is the elderly generation capable.pdf\u003cbr\u003e\nHeart failure.mp4\u003cbr\u003e\nHeart failure.pdf\u003cbr\u003e\nHermite based T-wave morphology quantification improves LQTS diagnosis.pdf\u003cbr\u003e\nHigh density mapping for qtrial tachyarrhythmias.mp4\u003cbr\u003e\nHigh density mapping for qtrial tachyarrhythmias.pdf\u003cbr\u003e\nHigh power short duration radio frequency applications.mp4\u003cbr\u003e\nHigh power short duration radio frequency applications.pdf\u003cbr\u003e\nHigh resolution imaging and computer modelling – New insight in post-infarct ventricular tachycardia substrates.mp4\u003cbr\u003e\nHigh resolution imaging and computer modelling – New insight in post-infarct ventricular tachycardia substrates.pdf\u003cbr\u003e\nHigh-density 3D mapping of a stable atrial tachycardia.pdf\u003cbr\u003e\nHigh-risk features and event predictors in patients with unexplained syncope from the young SCD-SOS cohort.pdf\u003cbr\u003e\nHigher left atrial pressure is predictive for atrial fibrillation recurrence after pulmonary vein isolation.pdf\u003cbr\u003e\nHis bundle pacing initial experience after 209 procedures.mp4\u003cbr\u003e\nHis bundle pacing initial experience after 209 procedures.pdf\u003cbr\u003e\nHomogenization of low voltage areas in sinus rhythm for the ablation of persistent atrial fibrillation.pdf\u003cbr\u003e\nHow to anticipate clinical outcomes. Any impact on mortality.mp4\u003cbr\u003e\nHow to anticipate clinical outcomes. Any impact on mortality.pdf\u003cbr\u003e\nHow to deal with data dumping.mp4\u003cbr\u003e\nHow to deal with data dumping.pdf\u003cbr\u003e\nHow to get your paper published – Tips and tricks from the Editor-in-Chief.mp4\u003cbr\u003e\nHow to get your paper published – Tips and tricks from the Editor-in-Chief.pdf\u003cbr\u003e\nHow to interpret difficult ECGs and intracardiac electrograms – Part 1.mp4\u003cbr\u003e\nHow to interpret difficult ECGs and intracardiac electrograms – Part 1.pdf\u003cbr\u003e\nHow to master ECG ventricular tachycardia morphology to direct ablation and define strategy.mp4\u003cbr\u003e\nHow to master ECG ventricular tachycardia morphology to direct ablation and define strategy.pdf\u003cbr\u003e\nHow to predict the site of origin – Increasing efficiency by using all the available tools.mp4\u003cbr\u003e\nHow to predict the site of origin – Increasing efficiency by using all the available tools.pdf\u003cbr\u003e\nHuman iPSC-derived cardiomyocytes as cell-based platform to study cardiac senescence.mp4\u003cbr\u003e\nHuman iPSC-derived cardiomyocytes as cell-based platform to study cardiac senescence.pdf\u003cbr\u003e\nHuman iPSC-derived cardiomyocytes in electrophysiology what are they good for.mp4\u003cbr\u003e\nHuman iPSC-derived cardiomyocytes in electrophysiology what are they good for.pdf\u003cbr\u003e\nHypertrophic cardiomyopathy and sports.mp4\u003cbr\u003e\nHypertrophic cardiomyopathy and sports.pdf\u003cbr\u003e\niBox-CRT Can we do it better.pdf\u003cbr\u003e\niBox-CRT Optimizing CRT implant without compromising procedure duration.pdf\u003cbr\u003e\nICD programming – Optimising arrhythmia detection and termination.mp4\u003cbr\u003e\nICD programming – Optimising arrhythmia detection and termination.pdf\u003cbr\u003e\nICDs in athletes.mp4\u003cbr\u003e\nICDs in athletes.pdf\u003cbr\u003e\nIdentification of the A293 (AVE1231) binding site in the cardiac two-pore-domain potassium channel TASK-1.mp4\u003cbr\u003e\nIdentification of the A293 (AVE1231) binding site in the cardiac two-pore-domain potassium channel TASK-1.pdf\u003cbr\u003e\nIdiopathic ventricular fibrillation – Diagnostic pathway and therapeutic strategies.mp4\u003cbr\u003e\nIdiopathic ventricular fibrillation – Diagnostic pathway and therapeutic strategies.pdf\u003cbr\u003e\nILR monitoring in 2019 for arrhythmia detection – When and in whom.mp4\u003cbr\u003e\nILR monitoring in 2019 for arrhythmia detection – When and in whom.pdf\u003cbr\u003e\nImage-integrated ventricular tachycardia ablation results from the international MUSIC VT registry.pdf\u003cbr\u003e\nImpact and cost-effectiveness of long-term intermittent PPG monitoring in stroke patients.pdf\u003cbr\u003e\nImpact of ablation index on paroxysmal atrial fibrillation ablation.pdf\u003cbr\u003e\nImpact of baseline patient characteristics on optimal programming.pdf\u003cbr\u003e\nImpact of cardiac tachyarrhtythmias recorded in Coronary Intensive Care Unit (CICU) on short and long-term mortality.pdf\u003cbr\u003e\nImpact of cryoballoon freeze duration on durability of pulmonary vein isolation insights from re-mapping procedures.pdf\u003cbr\u003e\nImpact of different types of implanted pacemaker on endpoints in patients with sick sinus syndrome in follow-up study.pdf\u003cbr\u003e\nImpact of genetic mutation type on long-term outcome of endo-epicardial ablation of ventricular tachycardia in patients.mp4\u003cbr\u003e\nImpact of genetic mutation type on long-term outcome of endo-epicardial ablation of ventricular tachycardia in patients.pdf\u003cbr\u003e\nImpact of mapping points in high density mapping of the left atrium.pdf\u003cbr\u003e\nImpact of promoting intrinsic ventricular rhythm on clinical outcomes in pacemaker patients at one-year post implant.pdf\u003cbr\u003e\nImpact of radiofrequency wide circumferential pulmonary vein isolation on left atrial geometry in patients.pdf\u003cbr\u003e\nImpact of the mean left atrial pressure on the clinical outcome of patients after catheter ablation for atrial fibrillation.pdf\u003cbr\u003e\nImpact of transcatheter mitral valve repair on ventricular arrhythmias.pdf\u003cbr\u003e\nImplantable loop recorder detected burden of atrial fibrillation following cryoballoon pulmonary vein isolation in patients.pdf\u003cbr\u003e\nImplantation of the Micra transcatheter pacing system bleeding and thromboembolic events in a real-world setting.mp4\u003cbr\u003e\nImplantation of the Micra transcatheter pacing system bleeding and thromboembolic events in a real-world setting.pdf\u003cbr\u003e\nImplantation technique.mp4\u003cbr\u003e\nImplantation technique.pdf\u003cbr\u003e\nImplementation of a pulse-deriving smartphone application in high-risk populations for primary.pdf\u003cbr\u003e\nImproving the safety and efficiency of CIED implantation procedures with pre-procedural contrast-enhanced venography.pdf\u003cbr\u003e\nIn arrhythmogenic right ventricular dysplasia.mp4\u003cbr\u003e\nIn arrhythmogenic right ventricular dysplasia.pdf\u003cbr\u003e\nIn Brugada syndrome.mp4\u003cbr\u003e\nIn Brugada syndrome.pdf\u003cbr\u003e\nIn dilated cardiomyopathy.mp4\u003cbr\u003e\nIn dilated cardiomyopathy.pdf\u003cbr\u003e\nIn the presence of mechanical assist devices.mp4\u003cbr\u003e\nIn the presence of mechanical assist devices.pdf\u003cbr\u003e\nIn-hospital and long-term prognosis in patients after the implantation of implantable cardioverter-defibrillators.pdf\u003cbr\u003e\nIn-vitro analysis of the origin and characteristics of gaseous micro-emboli during catheter electroporation ablation.pdf\u003cbr\u003e\nIncessant narrow-complex-tachycardia in a patient with heart failure – What is the mechanism.pdf\u003cbr\u003e\nIncidence and evolution of esophageal lesions post-pulmonary vein isolation.pdf\u003cbr\u003e\nIncidence and natural course of arrhythmias in grown-ups with a congenital heart defect.mp4\u003cbr\u003e\nIncidence and natural course of arrhythmias in grown-ups with a congenital heart defect.pdf\u003cbr\u003e\nIncidence of appropriate therapy and mortality after ICD generator replacement.mp4\u003cbr\u003e\nIncidence of appropriate therapy and mortality after ICD generator replacement.pdf\u003cbr\u003e\nIncidence of early adenosine-induced dormant conduction through cavo-tricuspid isthmus after radiofrequency.pdf\u003cbr\u003e\nIncidence of supraventricular tachycardia after catheter ablation of atrial fibrillation.mp4\u003cbr\u003e\nIncidence of supraventricular tachycardia after catheter ablation of atrial fibrillation.pdf\u003cbr\u003e\nIndependent sources of initial atrial activity as the cause of arrhythmia in a rat model of alcoholic cardiomyopathy.pdf\u003cbr\u003e\nIndexes of anticoagulation control and major adverse outcomes in patients with atrial fibrillation.pdf\u003cbr\u003e\nIndications for ICD implantation for prevention of sudden cardiac death – Current practice and challenges.mp4\u003cbr\u003e\nIndications for ICD implantation for prevention of sudden cardiac death – Current practice and challenges.pdf\u003cbr\u003e\nInducibility of ventricular fibrillation during subcutaneous implantable cardioverter – defibrillator implantation.pdf\u003cbr\u003e\nInfection of cardiac implantable electronic devices and the need for subsequent re-implantation.pdf\u003cbr\u003e\nInfluence of pulmonary vein isolation by means of the second generation cryoballoon on autonomic function in patients.pdf\u003cbr\u003e\nInfluence of right ventricular pacing on progression of tricuspid regurgitation after implantation of transvenous.pdf\u003cbr\u003e\nInfluence of the descending aorta on the fibrosis of the posterior left atrial wall.pdf\u003cbr\u003e\nIntegrating new approaches to atrial fibrillation management.mp4\u003cbr\u003e\nIntegrating new approaches to atrial fibrillation management.pdf\u003cbr\u003e\nInter-operator reproducibility of pulmonary vein isolation guided by the ablation index.pdf\u003cbr\u003e\nInterconnection the characteristics of orthostatic resistance and arterial baroreflex sensitivity in patients.pdf\u003cbr\u003e\nIntercontinental lecture – Ventricular tachycardia ablation.mp4\u003cbr\u003e\nIntercontinental lecture – Ventricular tachycardia ablation.pdf\u003cbr\u003e\nInternal vs. external electrical cardioversion of atrial arrhythmias in patients – Discussion.mp4\u003cbr\u003e\nInternal vs. external electrical cardioversion of atrial arrhythmias in patients – Discussion.pdf\u003cbr\u003e\nInternal vs. external electrical cardioversion of atrial arrhythmias in patients.mp4\u003cbr\u003e\nInternal vs. external electrical cardioversion of atrial arrhythmias in patients.pdf\u003cbr\u003e\nInterplay of atrial fibrillation, heart failure and chemotherapy.mp4\u003cbr\u003e\nInterplay of atrial fibrillation, heart failure and chemotherapy.pdf\u003cbr\u003e\nInterstitial fibrosis area, left atrial volume, and left atrial strain predicts atrial fibrillation recurrence.pdf\u003cbr\u003e\nIntra-operative paced LV-RV interlead electrical delay and cardiac resynchronization therapy response.pdf\u003cbr\u003e\nIntrinsic conduction enhancement in bradycardia pacing – How far to go Until Wenckebach comes.mp4\u003cbr\u003e\nIntrinsic conduction enhancement in bradycardia pacing – How far to go Until Wenckebach comes.pdf\u003cbr\u003e\nIntrinsic conduction enhancement in bradycardia pacing – How far to go Wait for the long PR – I’ll be there.mp4\u003cbr\u003e\nIntrinsic conduction enhancement in bradycardia pacing – How far to go Wait for the long PR – I’ll be there.pdf\u003cbr\u003e\nIntroduction – The growing prevalence of Atrial Fibrilation (AF).mp4\u003cbr\u003e\nIntroduction – Who should receive the Wearable Cardioverter Defibrillator (WCD).mp4\u003cbr\u003e\nIntroduction – Who should receive the Wearable Cardioverter Defibrillator (WCD).pdf\u003cbr\u003e\nIntroduction Advanced technologies for personalised disease management.mp4\u003cbr\u003e\nIntroduction Illuminating electrophysiology from the simple to complex procedures.mp4\u003cbr\u003e\nIntroductions \u0026amp; Awards.mp4\u003cbr\u003e\nIntroductions \u0026amp; Awards.pdf\u003cbr\u003e\nInvestigation of the Na+ Ca2+-exchanger-funny current crosstalk in sinus-node and Purkinje fibre assessed.pdf\u003cbr\u003e\nInvestigation of the Na+- Ca2+-exchanger-funny current crosstalk in sinus-node and Purkinje fibre assessed.mp4\u003cbr\u003e\nIs atrio-ventricular node ablation a neglected option after failure of atrial fibrillation ablation.pdf\u003cbr\u003e\nIs certification realistic for nurses and allied health professionals in Europe.mp4\u003cbr\u003e\nIs certification realistic for nurses and allied health professionals in Europe.pdf\u003cbr\u003e\nIs compliance to heart rhythm monitoring an indication of patient education.pdf\u003cbr\u003e\nIs it possible to predict CRT response by analyzing damaged-DNA in blood taken from coronary sinus.pdf\u003cbr\u003e\nIs MRI a risk for the patient.mp4\u003cbr\u003e\nIs MRI a risk for the patient.pdf\u003cbr\u003e\nIs there still a role for holters and traditional ILRs.mp4\u003cbr\u003e\nIs there still a role for holters and traditional ILRs.pdf\u003cbr\u003e\nItalian multicenter experience with a new active fixation quadripolar left ventricular lead.mp4\u003cbr\u003e\nItalian multicenter experience with a new active fixation quadripolar left ventricular lead.pdf\u003cbr\u003e\nLaminopathy.mp4\u003cbr\u003e\nLaminopathy.pdf\u003cbr\u003e\nLarge repolarization gradients increase susceptibility to trigger-induced arrhythmias and are not reflected by QT time.pdf\u003cbr\u003e\nLate pacemaker implantation after transcutaneous aortic valve implantation.mp4\u003cbr\u003e\nLate pacemaker implantation after transcutaneous aortic valve implantation.pdf\u003cbr\u003e\nLatest insights from the catecholaminergic polymorphic ventricular tachycardia (CPVT) registry.mp4\u003cbr\u003e\nLatest insights from the catecholaminergic polymorphic ventricular tachycardia (CPVT) registry.pdf\u003cbr\u003e\nLead positioning for cardiac resynchronization therapy, a randomized trial comparing an active fixation bipolar.pdf\u003cbr\u003e\nLead related venous narrowing and occlusion. The scale of the problem – Lesson from 2105 TLE procedures.pdf\u003cbr\u003e\nLeadless dual chamber pacing.mp4\u003cbr\u003e\nLeadless dual chamber pacing.pdf\u003cbr\u003e\nLeadless pacemaker implantation in subacute humoral rejection in cardiac transplantation.pdf\u003cbr\u003e\nLeft atrial appendage closure – Alternative for oral anticoagulants in high risk atrial fibrillation patients.mp4\u003cbr\u003e\nLeft atrial appendage closure – Alternative for oral anticoagulants in high risk atrial fibrillation patients.pdf\u003cbr\u003e\nLeft atrial appendage occluders – Implantation technique.mp4\u003cbr\u003e\nLeft atrial appendage occluders – Implantation technique.pdf\u003cbr\u003e\nLeft atrial appendage occluders – Indications.mp4\u003cbr\u003e\nLeft atrial appendage occluders – Indications.pdf\u003cbr\u003e\nLeft atrial pressure and left atrial fibrosis predict outcome of catheter ablation of atrial fibrillation.pdf\u003cbr\u003e\nLeft bundle branch block (LBBB) or RV-paced induced LBBB post trans catheter aortic-valve replacement (TAVR) results.pdf\u003cbr\u003e\nLeft phrenic nerve injury during cryoballoon ablation of atrial fibrillation.pdf\u003cbr\u003e\nLeft ventricular scar predicts remodeling in patients undergoing cardiac resynchronisation therapy.pdf\u003cbr\u003e\nLeft ventricular septal pacing as a single ventricular lead approach to cardiac resynchronization therapy.mp4\u003cbr\u003e\nLeft ventricular septal pacing as a single ventricular lead approach to cardiac resynchronization therapy.pdf\u003cbr\u003e\nLevels of anxiety in patients with persistent atrial fibrillation undergoing elective cardioversion.pdf\u003cbr\u003e\nLife threatening ventricular tachycardia radiofrequency ablation in myocarditis.pdf\u003cbr\u003e\nLive from Leipzig – Atrial fibrillation ablation for persistent atrial fibrillation with the cryoballoon.mp4\u003cbr\u003e\nLive from Leipzig – Case of the day using Precision and a high density mapping catheter.mp4\u003cbr\u003e\nLive from Leipzig – Mechanical sheaths.mp4\u003cbr\u003e\nLive from Madrid – His bundle pacing in left bundle branch block.mp4\u003cbr\u003e\nLive from Madrid – LAMRT mapped with CARTO3 and a high definition multispline catheter.mp4\u003cbr\u003e\nLive in the box – Atrial fibrillation ablation using the ACUTUS system.mp4\u003cbr\u003e\nLive in the box – Atrial fibrillation ablation using the ACUTUS system.pdf\u003cbr\u003e\nLive in the box – Contiguous lesions using ablation index and interlesion distance the CLOSE approach.mp4\u003cbr\u003e\nLive in the box – Contiguous lesions using ablation index and interlesion distance the CLOSE approach.pdf\u003cbr\u003e\nLive in the box – Femoral snares.mp4\u003cbr\u003e\nLive in the box – Femoral snares.pdf\u003cbr\u003e\nLive in the box – His bundle pacing and atrioventricular node ablation.mp4\u003cbr\u003e\nLive in the box – His bundle pacing and atrioventricular node ablation.pdf\u003cbr\u003e\nLive in the box – His bundle pacing for infra-nodal atrioventricular block.mp4\u003cbr\u003e\nLive in the box – His bundle pacing for infra-nodal atrioventricular block.pdf\u003cbr\u003e\nLive in the box – Hybrid approach.mp4\u003cbr\u003e\nLive in the box – Hybrid approach.pdf\u003cbr\u003e\nLive in the box – LAMRT mapped Precision and a grid catheter.mp4\u003cbr\u003e\nLive in the box – LAMRT mapped Precision and a grid catheter.pdf\u003cbr\u003e\nLive in the box – Left atypical flutter mapped with the Rhythmia system.mp4\u003cbr\u003e\nLive in the box – Left atypical flutter mapped with the Rhythmia system.pdf\u003cbr\u003e\nLive in the box – Needle ablation.mp4\u003cbr\u003e\nLive in the box – Pacemap-guided ablation in ischaemic ventricular tachycardia patient.mp4\u003cbr\u003e\nLive in the box – Pacemap-guided ablation in ischaemic ventricular tachycardia patient.pdf\u003cbr\u003e\nLocation of ablation lesions guided by the acqmap system in atrial fibrillation ablation.pdf\u003cbr\u003e\nLong lasting persistent atrial fibrillation.mp4\u003cbr\u003e\nLong lasting persistent atrial fibrillation.pdf\u003cbr\u003e\nLong PR and interatrial conduction delay.mp4\u003cbr\u003e\nLong PR and interatrial conduction delay.pdf\u003cbr\u003e\nLong QT syndrome.mp4\u003cbr\u003e\nLong QT syndrome.pdf\u003cbr\u003e\nLong term impact of metabolic syndrome management on mortality in patients with atrial fibrillation.pdf\u003cbr\u003e\nLong term results of the leadless CRT (WiSE-CRT) in patients with failed implantation of a conventional CRT device.pdf\u003cbr\u003e\nLong-term clinical outcomes after upgrading permanent right ventricular pacemaker to biventricular stimulation.pdf\u003cbr\u003e\nLong-term follow-up after an acute myocardial infarction to explore the stability of the arrhythmogenic substrate.mp4\u003cbr\u003e\nLong-term follow-up after an acute myocardial infarction to explore the stability of the arrhythmogenic substrate.pdf\u003cbr\u003e\nLong-term follow-up of the patients with pacemaker leads implanted through persistent left superior vena cava.pdf\u003cbr\u003e\nLong-term outcome after cryoballoon pulmonary vein isolation when measuring pv isolation or not measuring pv isolation.pdf\u003cbr\u003e\nLong-term outcomes in paroxysmal and persistent atrial fibrillation using high density voltage mapping with ablation.pdf\u003cbr\u003e\nLong-term outcomes in patients with and without left bundle branch block undergoing electroanatomic mapping system.pdf\u003cbr\u003e\nLong-term outcomes in patients with atrio-ventricular block of unknown aetiology identified before the age of 50 years.mp4\u003cbr\u003e\nLong-term outcomes in patients with atrio-ventricular block of unknown aetiology identified before the age of 50 years.pdf\u003cbr\u003e\nLong-term performance of contemporary internal cardioverter defibrillator leads a single center experience.mp4\u003cbr\u003e\nLong-term performance of contemporary internal cardioverter defibrillator leads a single center experience.pdf\u003cbr\u003e\nLong-term performance of the medtronic select-secure pacing lead in His and non-His bundle positions.pdf\u003cbr\u003e\nLong-term post-infarction scar volume decrease is associated to local wall thickening.pdf\u003cbr\u003e\nLow risk atrial fibrillation patients – Always anticoagulation.mp4\u003cbr\u003e\nLow risk atrial fibrillation patients – Always anticoagulation.pdf\u003cbr\u003e\nLow voltage electrotherapy for atrial arrhythmias – First-in-human.mp4\u003cbr\u003e\nLow voltage electrotherapy for atrial arrhythmias – First-in-human.pdf\u003cbr\u003e\nLVOT and LV summit.mp4\u003cbr\u003e\nLVOT and LV summit.pdf\u003cbr\u003e\nLyme disease.mp4\u003cbr\u003e\nLyme disease.pdf\u003cbr\u003e\nMachine learning classifiers for predicting catheter ablation responses using non-contact electrograms.pdf\u003cbr\u003e\nMachine learning pipeline for the automatic identification of a left ventricular tachycardia site of origin from 12-lead surface.pdf\u003cbr\u003e\nMagnetic resonance imaging safety in patients with cardiac implantable electronic devices -current status.pdf\u003cbr\u003e\nMahaim pathways.mp4\u003cbr\u003e\nMahaim pathways.pdf\u003cbr\u003e\nMain themes for the current Board.mp4\u003cbr\u003e\nMain themes for the current Board.pdf\u003cbr\u003e\nMale 50 years persistent atrial fibrillation no symptoms.mp4\u003cbr\u003e\nMale 50 years persistent atrial fibrillation no symptoms.pdf\u003cbr\u003e\nManaged remote monitoring using a vendor-neutral software system a retrospective analysis of 10,000 patients.pdf\u003cbr\u003e\nManagement in the emergency department – Immediate risk stratification.mp4\u003cbr\u003e\nManagement in the emergency department – Immediate risk stratification.pdf\u003cbr\u003e\nManaging complications following epicardial puncture.mp4\u003cbr\u003e\nManaging complications following epicardial puncture.pdf\u003cbr\u003e\nManaging the reperfusion ventricular tachyarrhythmias-focus on a perfused myocardium.pdf\u003cbr\u003e\nManaging Ventricular Tachycardias (VT) – ablation or pacing.mp4\u003cbr\u003e\nManaging Ventricular Tachycardias (VT) – ablation or pacing.pdf\u003cbr\u003e\nMapping and ablation of slow conduction potentials as an effective end-point of ischemic ventricular tachycardia ablation.pdf\u003cbr\u003e\nMapping atypical flutter using a high-density grid-style catheter utilization and customization.pdf\u003cbr\u003e\nMapping persistent atrial fibrillation with a high-density grid-style catheter.pdf\u003cbr\u003e\nMassive expansion of native human atrial cardiomyocytes by immortogenetics for multiscale arrhythmia research.mp4\u003cbr\u003e\nMassive expansion of native human atrial cardiomyocytes by immortogenetics for multiscale arrhythmia research.pdf\u003cbr\u003e\nMechanisms of action of cardiac resynchronisation therapy by his bundle pacing in patients with heart failure and LBBB.mp4\u003cbr\u003e\nMechanisms of action of cardiac resynchronisation therapy by his bundle pacing in patients with heart failure and LBBB.pdf\u003cbr\u003e\nMicroRNA as a predictor of successful atrial fibrillation ablation.pdf\u003cbr\u003e\nMiniaturized implantable loop recorders in a pediatric cohort.pdf\u003cbr\u003e\nMinimal defibrillation thresholds determined by step-down defibrillation testing in subcutaneous.mp4\u003cbr\u003e\nMinimal defibrillation thresholds determined by step-down defibrillation testing in subcutaneous.pdf\u003cbr\u003e\nMinimise bleeding complications – How to manage heparin, warfarin and NOACs.mp4\u003cbr\u003e\nMinimise bleeding complications – How to manage heparin, warfarin and NOACs.pdf\u003cbr\u003e\nMitral valve disease.mp4\u003cbr\u003e\nMitral valve disease.pdf\u003cbr\u003e\nMock EHRA device certification exam, how knowlegeable are you.mp4\u003cbr\u003e\nMock EHRA device certification exam, how knowlegeable are you.pdf\u003cbr\u003e\nModes of death of patients with implanted ICD results of a pilot trial.pdf\u003cbr\u003e\nMortality and morbidity reduction after frequent PVC ablation in patients with LV systolic dysfunction.mp4\u003cbr\u003e\nMortality and morbidity reduction after frequent PVC ablation in patients with LV systolic dysfunction.pdf\u003cbr\u003e\nMortality in atrial fibrillation.mp4\u003cbr\u003e\nMortality in atrial fibrillation.pdf\u003cbr\u003e\nMRIs in non-conditional devices.mp4\u003cbr\u003e\nMRIs in non-conditional devices.pdf\u003cbr\u003e\nMulticenter experience with the second generation of subcutaneous implantable cardioverter defibrillator.pdf\u003cbr\u003e\nMulticentre experience with the bidirectional rotational evolution RL mechanical sheath for lead extraction.pdf\u003cbr\u003e\nMultimodality imaging in selecting and guiding left ventricular placement.mp4\u003cbr\u003e\nMultimodality imaging in selecting and guiding left ventricular placement.pdf\u003cbr\u003e\nMultiple co-morbidities – A reason for CRT denial.mp4\u003cbr\u003e\nMultiple co-morbidities – A reason for CRT denial.pdf\u003cbr\u003e\nMUSIC-guided ablation of scar-related VT towards a shorter and more standardized procedure.pdf\u003cbr\u003e\nMy favourite approach for haemodynamically unstable ischaemic and non-ischaemic – A Arenal Maiz (Madrid,ES).mp4\u003cbr\u003e\nMy favourite approach for haemodynamically unstable ischaemic and non-ischaemic – A Arenal Maiz (Madrid,ES).pdf\u003cbr\u003e\nMy favourite approach for haemodynamically unstable ischaemic and non-ischaemic – K Soejima (Tokyo,JP).mp4\u003cbr\u003e\nMy favourite approach for haemodynamically unstable ischaemic and non-ischaemic – K Soejima (Tokyo,JP).pdf\u003cbr\u003e\nMy favourite approach for haemodynamically unstable ischaemic and non-ischaemic – P Maury (Toulouse,FR).mp4\u003cbr\u003e\nMy favourite approach for haemodynamically unstable ischaemic and non-ischaemic – P Maury (Toulouse,FR).pdf\u003cbr\u003e\nMy ICD candidate has a long PR interval (280 ms) – Which device to implant.mp4\u003cbr\u003e\nMy ICD candidate has a long PR interval (280 ms) – Which device to implant.pdf\u003cbr\u003e\nMy ICD patient has effective antitachycardia pacing – Does he she benefit from ablation or medication.mp4\u003cbr\u003e\nMy ICD patient has effective antitachycardia pacing – Does he she benefit from ablation or medication.pdf\u003cbr\u003e\nMy nightmare in lead management – Me too.mp4\u003cbr\u003e\nMy nightmare in lead management – Me too.pdf\u003cbr\u003e\nMy patient has short-lasting atrial high-rate episodes at follow-up – Where to go from here.mp4\u003cbr\u003e\nMy patient has short-lasting atrial high-rate episodes at follow-up – Where to go from here.pdf\u003cbr\u003e\nMy patient has tricuspid regurgitation – What to do with my lead.mp4\u003cbr\u003e\nMy patient has tricuspid regurgitation – What to do with my lead.pdf\u003cbr\u003e\nMy patient with an ICD creatively provocative.mp4\u003cbr\u003e\nMy patient with neurally mediated syncope – Minimise symptoms by dedicated pacing algorithms.mp4\u003cbr\u003e\nMy patient with neurally mediated syncope – Minimise symptoms by dedicated pacing algorithms.pdf\u003cbr\u003e\nMy patient with recurrent episodes but uncertain diagnosis – Efficient work-up.mp4\u003cbr\u003e\nMy patient with recurrent episodes but uncertain diagnosis – Efficient work-up.pdf\u003cbr\u003e\nMy patient with syncope wants to continue driving – When.mp4\u003cbr\u003e\nMy patient with syncope wants to continue driving – When.pdf\u003cbr\u003e\nMy patient with VT ablation what does banking have in common with electrophysiology.mp4\u003cbr\u003e\nMy standard workflow – K Chun (Frankfurt,DE).mp4\u003cbr\u003e\nMy standard workflow – K Chun (Frankfurt,DE).pdf\u003cbr\u003e\nMy standard workflow – M Grimaldi (Bari,IT).mp4\u003cbr\u003e\nMy standard workflow – M Grimaldi (Bari,IT).pdf\u003cbr\u003e\nMy standard workflow – O Wazni (Cleveland,US).mp4\u003cbr\u003e\nMy standard workflow – O Wazni (Cleveland,US).pdf\u003cbr\u003e\nMy standard workflow – S Richter (Leipzig,DE).mp4\u003cbr\u003e\nMy standard workflow – S Richter (Leipzig,DE).pdf\u003cbr\u003e\nMy Top 10 messages from the ESC Guidelines 2018.mp4\u003cbr\u003e\nMy Top 10 messages from the ESC Guidelines 2018.pdf\u003cbr\u003e\nMyocardial damage as a result of implantation and defibrillation testing in transvenous and subcutaneous.mp4\u003cbr\u003e\nMyocardial damage as a result of implantation and defibrillation testing in transvenous and subcutaneous.pdf\u003cbr\u003e\nMyocardial minimal damage after rapid ventricular pacing, the prospective randomized multicenter MyDate-trial.pdf\u003cbr\u003e\nMyocarditis with prevalent arrhythmic manifestation clinical features and outcome during long-term follow up.pdf\u003cbr\u003e\nNanosecond pulsed electric field excites cardiac myocytes via induction of slow sustained depolarization.pdf\u003cbr\u003e\nNarrow QRS tachycardias – Part 1.mp4\u003cbr\u003e\nNarrow QRS tachycardias – Part 1.pdf\u003cbr\u003e\nNew energy sources and applications for ventricular tachycardia ablation.mp4\u003cbr\u003e\nNew energy sources and applications for ventricular tachycardia ablation.pdf\u003cbr\u003e\nNew tools for epicardial access.mp4\u003cbr\u003e\nNew tools for epicardial access.pdf\u003cbr\u003e\nNon invasive cardiac radiation for ablation of ventricular tachycardia.mp4\u003cbr\u003e\nNon invasive cardiac radiation for ablation of ventricular tachycardia.pdf\u003cbr\u003e\nNon-familial sick sinus syndrome search for genetic markers.pdf\u003cbr\u003e\nNon-invasive atrial fibrosis assessment using LGE CMR imaging is reproducible using an open source.mp4\u003cbr\u003e\nNon-invasive atrial fibrosis assessment using LGE CMR imaging is reproducible using an open source.pdf\u003cbr\u003e\nNoninvasive panoramic mapping of electrical rotors with multivariate signal complexity analysis in patients.mp4\u003cbr\u003e\nNoninvasive panoramic mapping of electrical rotors with multivariate signal complexity analysis in patients.pdf\u003cbr\u003e\nNovel left parasternal epicardial access using a micropuncture kit.pdf\u003cbr\u003e\nNovel oral anticoagulant drugs or oral anticoagulant – What is best for the patient.mp4\u003cbr\u003e\nNovel oral anticoagulant drugs or oral anticoagulant – What is best for the patient.pdf\u003cbr\u003e\nNovel ultra-low temperature cryoablation catheter improves ablation strategy to treat long standing persistent.pdf\u003cbr\u003e\nOccluded veins – Alternatives and solutions.mp4\u003cbr\u003e\nOccluded veins – Alternatives and solutions.pdf\u003cbr\u003e\nOesophageal fistula.mp4\u003cbr\u003e\nOesophageal fistula.pdf\u003cbr\u003e\nOne-year clinical outcome after pulmonary vein isolation with use of ablation index in patients with persistent atrial fibrillation.pdf\u003cbr\u003e\nOne-year follow-up results of cardiac contractility modulation in patients with heart failure with reduced ejection fraction.pdf\u003cbr\u003e\nOpening question – Addressing unknowns in CRT -1.mp4\u003cbr\u003e\nOpening question – Addressing unknowns in CRT -1.pdf\u003cbr\u003e\nOpening question – Addressing unknowns in CRT -2.mp4\u003cbr\u003e\nOpening question – Addressing unknowns in CRT -2.pdf\u003cbr\u003e\nOpening question – Controversies in atrial fibrillation ablation -1.mp4\u003cbr\u003e\nOpening question – Controversies in atrial fibrillation ablation -1.pdf\u003cbr\u003e\nOpening question – Controversies in atrial fibrillation ablation -2.mp4\u003cbr\u003e\nOpening question – Controversies in atrial fibrillation ablation -2.pdf\u003cbr\u003e\nOpening question – Knowledge gaps in clinical atrial fibrillation -1.mp4\u003cbr\u003e\nOpening question – Knowledge gaps in clinical atrial fibrillation -1.pdf\u003cbr\u003e\nOpening question – Knowledge gaps in clinical atrial fibrillation -2.mp4\u003cbr\u003e\nOpening question – Knowledge gaps in clinical atrial fibrillation -2.pdf\u003cbr\u003e\nOpening question – Ventricular tachycardia ablation in ischaemic cardiomyopathy – How early and how invasive -1.mp4\u003cbr\u003e\nOpening question – Ventricular tachycardia ablation in ischaemic cardiomyopathy – How early and how invasive -1.pdf\u003cbr\u003e\nOpening question – Ventricular tachycardia ablation in ischaemic cardiomyopathy – How early and how invasive -2.mp4\u003cbr\u003e\nOpening question – Ventricular tachycardia ablation in ischaemic cardiomyopathy – How early and how invasive -2.pdf\u003cbr\u003e\nOptimal blood pressure control for lowering dementia risk in patients with atrial fibrillation.pdf\u003cbr\u003e\nOptimal candidates for ablation in different clinical scenarios. Just a question of burden.mp4\u003cbr\u003e\nOptimal candidates for ablation in different clinical scenarios. Just a question of burden.pdf\u003cbr\u003e\nOptimal therapy of atrial fibrillation in patients with heart failure – Role of risk factor management and upstream therapies.mp4\u003cbr\u003e\nOptimal therapy of atrial fibrillation in patients with heart failure – Role of risk factor management and upstream therapies.pdf\u003cbr\u003e\nOptimal therapy of heart failure in patients with atrial fibrillation.mp4\u003cbr\u003e\nOptimal therapy of heart failure in patients with atrial fibrillation.pdf\u003cbr\u003e\nOutcomes of patients with arrhythmogenic right ventricular cardiomyopathy dysplasia after catheter ablation.mp4\u003cbr\u003e\nOutcomes of patients with arrhythmogenic right ventricular cardiomyopathy dysplasia after catheter ablation.pdf\u003cbr\u003e\nOverlap syndromes.mp4\u003cbr\u003e\nOverlap syndromes.pdf\u003cbr\u003e\nPacemaker dependency after transcatheter aortic valve implantation incidence, predictors and long-term outcomes.mp4\u003cbr\u003e\nPacemaker dependency after transcatheter aortic valve implantation incidence, predictors and long-term outcomes.pdf\u003cbr\u003e\nPacemaker dependency in patients with permanent pacemaker implantation after TAVI.mp4\u003cbr\u003e\nPacemaker dependency in patients with permanent pacemaker implantation after TAVI.pdf\u003cbr\u003e\nPacemaker programming – How to optimise therapy efficacy.mp4\u003cbr\u003e\nPacemaker programming – How to optimise therapy efficacy.pdf\u003cbr\u003e\nPacemakers \u0026amp; ICDs.mp4\u003cbr\u003e\nPacemakers \u0026amp; ICDs.pdf\u003cbr\u003e\nPacertool – patient specific biofeedback implantation system for pacemakers and CRT.pdf\u003cbr\u003e\nPacing above and beyond single chamber atrial pacing in a patient with a Mustard procedure and superior baffle obstruction.pdf\u003cbr\u003e\nPanel discussion – Case-based optimal therapy of atrial fibrillation.mp4\u003cbr\u003e\nPanel discussion – Clinical conundrums in patients with CIEDs.mp4\u003cbr\u003e\nPanel discussion – Critical appraisal of antiarrhythmic drug therapy – The science behind trial-and-error.mp4\u003cbr\u003e\nPanel discussion – Exploration of novel anti-fibrillatory strategies.mp4\u003cbr\u003e\nPanel discussion – Indications for atrial fibrillation ablation in difficult scenarios.mp4\u003cbr\u003e\nPanel discussion – Individualising CRT – A case-based approach.mp4\u003cbr\u003e\nPanel discussion – Invasive treatment of ventricular arrhythmias in distinct scenarios and etiologies.mp4\u003cbr\u003e\nPanel discussion – Late-breaking trials 4.mp4\u003cbr\u003e\nPanel discussion – Syncope – Translation of guidelines into clinical practice.mp4\u003cbr\u003e\nPanel discussion – When things get complicated in lead management – A case-based approach.mp4\u003cbr\u003e\nPanel discussion and summary – Who should receive the Wearable Cardioverter Defibrillator (WCD).mp4\u003cbr\u003e\nPanel discussion and summary – Who should receive the Wearable Cardioverter Defibrillator (WCD).pdf\u003cbr\u003e\nPatients with atrial fibrillation and a possibly temporary cause.pdf\u003cbr\u003e\nPatients with cryptogenic stroke – ILR for everyone – Cancelled.mp4\u003cbr\u003e\nPatients with four veins isolated at repeat – Incidence and characteristics.mp4\u003cbr\u003e\nPatients with four veins isolated at repeat – Incidence and characteristics.pdf\u003cbr\u003e\nPatients with permanent pacemakers upgraded to ICDs – Who takes two steps and why.pdf\u003cbr\u003e\nPerception on anticoagulant treatment and treatment convenience for patients switching from a vitamin K.pdf\u003cbr\u003e\nPeri-mitral flutter ablation where is the right way to isthmus block.mp4\u003cbr\u003e\nPeri-mitral flutter ablation where is the right way to isthmus block.pdf\u003cbr\u003e\nPericardial fat and the risk of atrial tachy-arrhythmia recurrence post pulmonary vein isolation.pdf\u003cbr\u003e\nPeriodic repolarization dynamics and risk of sudden cardiac death in patients with stable coronary artery disease.pdf\u003cbr\u003e\nPeriprocedural edoxaban management in routine clinical practice is associated with low bleeding risk.mp4\u003cbr\u003e\nPeriprocedural edoxaban management in routine clinical practice is associated with low bleeding risk.pdf\u003cbr\u003e\nPermanent junctional reciprocating tachycardia.mp4\u003cbr\u003e\nPermanent junctional reciprocating tachycardia.pdf\u003cbr\u003e\nPersistent and severe atrial septal defect after percutaneous left atrial appendage occlusion with the watchman device.pdf\u003cbr\u003e\nPersistent atrial fibrillation in the elderly. A possible association with arterial stiffness, hyperuricemia.pdf\u003cbr\u003e\nPersonalising Implantable Cardioverter Defibrillator (ICD) therapy for Sudden Cardiac Death (SCD) prevention.mp4\u003cbr\u003e\nPersonalising Implantable Cardioverter Defibrillator (ICD) therapy for Sudden Cardiac Death (SCD) prevention.pdf\u003cbr\u003e\nPersonalized interventional strategy in patients with long-standing persistent atrial fibrillation and chronic heart failure.mp4\u003cbr\u003e\nPersonalized interventional strategy in patients with long-standing persistent atrial fibrillation and chronic heart failure.pdf\u003cbr\u003e\nPersonalized single shot therapies innovative hot and cold balloons.mp4\u003cbr\u003e\nPersonalized single shot therapies innovative hot and cold balloons.pdf\u003cbr\u003e\nPharmacological inhibition of NHE3 dependent intestinal sodium absorption reduced arrhythmogenic remodelling in rats.pdf\u003cbr\u003e\nPhenotypic variance of a SCN5A nonsense mutation in a familial transmission.pdf\u003cbr\u003e\nPhospholamban (PLN) p.Arg14del cardiomyopathy.mp4\u003cbr\u003e\nPhospholamban (PLN) p.Arg14del cardiomyopathy.pdf\u003cbr\u003e\nPhrenic nerve injury during pulmonary vein isolation using the second-generation cryoballoon.mp4\u003cbr\u003e\nPhrenic nerve injury during pulmonary vein isolation using the second-generation cryoballoon.pdf\u003cbr\u003e\nPhysiological activation by his bundle pacing can introduce superior cardiac function compared with right.mp4\u003cbr\u003e\nPhysiological activation by his bundle pacing can introduce superior cardiac function compared with right.pdf\u003cbr\u003e\nPhysiology of direct His bundle pacing.mp4\u003cbr\u003e\nPhysiology of direct His bundle pacing.pdf\u003cbr\u003e\nPilot study evaluating MRI parameters for prediction of ablation induced esophageal injury after atrial.pdf\u003cbr\u003e\nPlanning a redo in patients with congenital heart disease.mp4\u003cbr\u003e\nPlanning a redo in patients with congenital heart disease.pdf\u003cbr\u003e\nPocket complications after cardiac implantable device implantation and replacement.pdf\u003cbr\u003e\nPopulation-specific genetic architecture in a representative patient cohort with LQT syndrome.pdf\u003cbr\u003e\nPost mortem pro life – should we analyse cardiac implantable electronic devices after death.pdf\u003cbr\u003e\nPOTS serum activates G-protein coupled receptors responsible for cardiovascular homeostasis and pain control.pdf\u003cbr\u003e\nPre-ablative scoring system for prediction of recurrence after PVI with cryo-balloon and optimization of ablation strategy.pdf\u003cbr\u003e\nPre-clinical experience with a novel, multi-polar radiofrequency balloon for pulmonary vein isolation.pdf\u003cbr\u003e\nPrediction of mortality and mode of death by clinical score systems for patients with atrial fibrillation.pdf\u003cbr\u003e\nPrediction of Thromboembolic Events in Anticoagulated Patients with Atrial Fibrillation.pdf\u003cbr\u003e\nPredictors for recurrence of atrial fibrillation following ablation of atrial fibrillation within the blanking period.pdf\u003cbr\u003e\nPredictors of clinical failure of transvenous lead extraction.pdf\u003cbr\u003e\nPredictors of long-term outcome in patients undergoing a first repeat ablation for atrial fibrillation consisting solely.pdf\u003cbr\u003e\nPreference of patients regarding the characteristics of new oral anticoagulants.pdf\u003cbr\u003e\nPreliminary experience of remote management of heart failure patients with the multisensor HeartLogic alert.pdf\u003cbr\u003e\nPreliminary experience with the multisensor HeartLogic algorithm for heart failure monitoring a case series report.pdf\u003cbr\u003e\nPremature ventricular contraction localisation based on the ECG.mp4\u003cbr\u003e\nPremature ventricular contraction localisation based on the ECG.pdf\u003cbr\u003e\nPrevalence and associated stroke risks of HIV in patients with atrial fibrillation a nationwide cohort study.pdf\u003cbr\u003e\nPrevalence and electrophysiological phenotype of SCN5A genetic variants identified in unexplained sudden.pdf\u003cbr\u003e\nPrevalence of Bayes syndrome in a large unselected infant population of north-western Transilvania.pdf\u003cbr\u003e\nPrevalence of interatrial block in a tertiary referral hospita.pdf\u003cbr\u003e\nPrevalence, management and outcome of life-threatening arrhythmias in Takotsubo Syndrome.pdf\u003cbr\u003e\nPrimary prevention in ischaemic cardiomyopathy. The continued quest for better risk stratification.mp4\u003cbr\u003e\nPrimary prevention in ischaemic cardiomyopathy. The continued quest for better risk stratification.pdf\u003cbr\u003e\nPrimary prophylactic ICD in non-ischaemic cardiomyopathy – Prophylactic ICD for almost everyone.mp4\u003cbr\u003e\nPrimary prophylactic ICD in non-ischaemic cardiomyopathy – Prophylactic ICD for almost everyone.pdf\u003cbr\u003e\nPrimary prophylactic ICD in non-ischaemic cardiomyopathy – Prophylactic ICD only for highly selected patients.mp4\u003cbr\u003e\nPrimary prophylactic ICD in non-ischaemic cardiomyopathy – Prophylactic ICD only for highly selected patients.pdf\u003cbr\u003e\nProcedure planning, vein access and lead placement – Transvenous pacemakers.mp4\u003cbr\u003e\nProcedure planning, vein access and lead placement – Transvenous pacemakers.pdf\u003cbr\u003e\nProcedure planning, vein access and pacemaker placement – Leadless pacemakers.mp4\u003cbr\u003e\nProcedure planning, vein access and pacemaker placement – Leadless pacemakers.pdf\u003cbr\u003e\nPrognostic significance of ventricular arrhythmias in titin-related dilated cardiomyopathy for the outcome.pdf\u003cbr\u003e\nProgramming and follow-up.mp4\u003cbr\u003e\nProgramming and follow-up.pdf\u003cbr\u003e\nProgression and clinical manifestations in screening-detected atrial fibrillation a five-year follow-up of the STROKESTOP study.pdf\u003cbr\u003e\nPulmonary arterial pressure predicts heart failure decompensation from recent onset frequent premature.pdf\u003cbr\u003e\nPulmonary vein anatomy and cryoballoon ablation does one size fits all.pdf\u003cbr\u003e\nPulmonary vein encirclement using an ablation index-guided point-by-point workflow.mp4\u003cbr\u003e\nPulmonary vein encirclement using an ablation index-guided point-by-point workflow.pdf\u003cbr\u003e\nPulmonary vein isolation by high-power short-duration radiofrequency applications.mp4\u003cbr\u003e\nPulmonary vein isolation by high-power short-duration radiofrequency applications.pdf\u003cbr\u003e\nPulmonary vein isolation by visually guided laser balloon ablation demonstrates excellent long-term follow-up results.pdf\u003cbr\u003e\nPulmonary vein isolation using a high power short duration CLOSE protocol towards a shorter procedure duration.pdf\u003cbr\u003e\nPulmonary vein isolation using ablation index improves outcome in patients with persistent AF.pdf\u003cbr\u003e\nPulmonary vein isolation using ablation index vs CLOSE protocol with a surround flow ablation catheter.pdf\u003cbr\u003e\nPulmonary vein isolation – Do you still need a circular mapping catheter.mp4\u003cbr\u003e\nPulmonary vein isolation – Do you still need a circular mapping catheter.pdf\u003cbr\u003e\nPure cardiac magnetic resonance-guided ablation of scar-dependent left ventricular tachycardia.mp4\u003cbr\u003e\nPure cardiac magnetic resonance-guided ablation of scar-dependent left ventricular tachycardia.pdf\u003cbr\u003e\nQR-max index in cardiac resynchronization.pdf\u003cbr\u003e\nQRS vector magnitude as a predictor of ventricular tachyarrhythmia in patients with brugada syndrome.pdf\u003cbr\u003e\nQT prolongation and conduction disturbances during chemotherapy.mp4\u003cbr\u003e\nQT prolongation and conduction disturbances during chemotherapy.pdf\u003cbr\u003e\nQuality of Anticoagulation Control and Major Adverse Outcomes in European Patients with Atrial Fibrillation.pdf\u003cbr\u003e\nQuality of life and 12-month efficacy outcomes in paroxysmal and persistent af following pvi using the pvac gold ablation.mp4\u003cbr\u003e\nQuality of life and 12-month efficacy outcomes in paroxysmal and persistent af following pvi using the pvac gold ablation.pdf\u003cbr\u003e\nQuiz 1.pdf\u003cbr\u003e\nQuiz 2 – EHRA ECG open.pdf\u003cbr\u003e\nQuiz 2 – EHRA EP tracings open.pdf\u003cbr\u003e\nQuiz 3.pdf\u003cbr\u003e\nQuiz 4.pdf\u003cbr\u003e\nRate responsive pacing and atrial high rate episodes in CRT patients. Lowering heart rate is key.pdf\u003cbr\u003e\nRationale behind development of novel drugs for atrial arrhythmias.mp4\u003cbr\u003e\nRationale behind development of novel drugs for atrial arrhythmias.pdf\u003cbr\u003e\nReablation in supraventricular tachycardia associated with younger age and negatively associated.pdf\u003cbr\u003e\nReactivity of autonomic nervous system in patients with ventricular arrhythmias.pdf\u003cbr\u003e\nRebuttal – Addressing unknowns in CRT -1.mp4\u003cbr\u003e\nRebuttal – Addressing unknowns in CRT -2.mp4\u003cbr\u003e\nRebuttal – Addressing unknowns in CRT -2.pdf\u003cbr\u003e\nRebuttal – Debates in cardiac pacing -1.mp4\u003cbr\u003e\nRebuttal – Debates in cardiac pacing -2.mp4\u003cbr\u003e\nRebuttal – Debates in ICD indications -1.mp4\u003cbr\u003e\nRebuttal – Debates in ICD indications -2.mp4\u003cbr\u003e\nRebuttal – Debates in ICD indications -3.mp4\u003cbr\u003e\nRebuttal – Debates in ICD indications -4.mp4\u003cbr\u003e\nRebuttal – Ventricular tachycardia ablation in ischaemic cardiomyopathy – How early and how invasive -1.mp4\u003cbr\u003e\nRebuttal – Ventricular tachycardia ablation in ischaemic cardiomyopathy – How early and how invasive -2.mp4\u003cbr\u003e\nRebuttal – Ventricular tachycardia ablation in ischaemic cardiomyopathy – How early and how invasive -3.mp4\u003cbr\u003e\nRebuttal CONTRA -1.mp4\u003cbr\u003e\nRebuttal CONTRA -1.pdf\u003cbr\u003e\nRebuttal CONTRA -2.mp4\u003cbr\u003e\nRebuttal PRO -1.mp4\u003cbr\u003e\nRebuttal PRO -1.pdf\u003cbr\u003e\nRebuttal PRO -2.mp4\u003cbr\u003e\nRedefining patient pathways for early diagnosis of cardiac arrhythmias through integrated care and centralised ECG.pdf\u003cbr\u003e\nReduce how do device algorithms reduce AF.mp4\u003cbr\u003e\nReduce how do device algorithms reduce AF.pdf\u003cbr\u003e\nReduced incidence of safety endpoints in cryoballoon ablation utilizing time-to-isolation guided cryoenergy dosing.pdf\u003cbr\u003e\nRedundant leads.mp4\u003cbr\u003e\nRedundant leads.pdf\u003cbr\u003e\nRefining ICD decision-making in non-ischaemic patients in the post-DANISH era.mp4\u003cbr\u003e\nRefining ICD decision-making in non-ischaemic patients in the post-DANISH era.pdf\u003cbr\u003e\nReflex syncope – To implant or not to implant a pacemaker.mp4\u003cbr\u003e\nReflex syncope – To implant or not to implant a pacemaker.pdf\u003cbr\u003e\nRelevant anatomy to master supraventricular tachycardia ablation.mp4\u003cbr\u003e\nRelevant anatomy to master supraventricular tachycardia ablation.pdf\u003cbr\u003e\nRemote monitoring an atrial fibrillation recurrence after ablation defining a recurrence endpoint.pdf\u003cbr\u003e\nRemote supervision to decrease hospitalization rate study (RESULT) in patients with heart failure – Discussion.mp4\u003cbr\u003e\nRemote supervision to decrease hospitalization rate study (RESULT) in patients with heart failure – Discussion.pdf\u003cbr\u003e\nRemote supervision to decrease hospitalization rate study (RESULT) in patients with heart failure.mp4\u003cbr\u003e\nRemote supervision to decrease hospitalization rate study (RESULT) in patients with heart failure.pdf\u003cbr\u003e\nRemoval of a large vegetation using the angioVac aspiration system in a patient with device-related infection.pdf\u003cbr\u003e\nReplacing a coronary vein lead – An easy job with the right tools.mp4\u003cbr\u003e\nReplacing a coronary vein lead – An easy job with the right tools.pdf\u003cbr\u003e\nRespond how to ensure therapy delivery during AF.mp4\u003cbr\u003e\nRespond how to ensure therapy delivery during AF.pdf\u003cbr\u003e\nRight atrial electrogram complexity predicts sustained induced atrial fibrillation after pulmonary vein isolation.pdf\u003cbr\u003e\nRight atrial volume progression is associated with atrial fibrillation recurrence after catheter ablation.pdf\u003cbr\u003e\nRight bundle branch block – Yes, no, maybe.mp4\u003cbr\u003e\nRight bundle branch block – Yes, no, maybe.pdf\u003cbr\u003e\nRight ventricular dysfunction in CRT – What to do.mp4\u003cbr\u003e\nRight ventricular dysfunction in CRT – What to do.pdf\u003cbr\u003e\nRisk factors for ventricular arrhythmias in cardiac-variant fabry disease.pdf\u003cbr\u003e\nRisk of electromagnetic interference in the daily environment.mp4\u003cbr\u003e\nRisk of electromagnetic interference in the daily environment.pdf\u003cbr\u003e\nRisk of progression to malignant ventricular arrhythmia’s in carriers of the cardiomyopathy causing (PLN) p.Arg14del.pdf\u003cbr\u003e\nRisk stratification in DCM – Value of LGE-CMR.mp4\u003cbr\u003e\nRisk stratification in DCM – Value of LGE-CMR.pdf\u003cbr\u003e\nRisk stratification of patients in syncope units.pdf\u003cbr\u003e\nRole of abnormal dispersion of ventricular repolarization as a risk factor for mortality in patients.mp4\u003cbr\u003e\nRole of abnormal dispersion of ventricular repolarization as a risk factor for mortality in patients.pdf\u003cbr\u003e\nRole of extensive diagnostic work-up with 3D electroanatomic mapping and endomyocardial biopsy in young.pdf\u003cbr\u003e\nRotor and phase mapping and ablation.mp4\u003cbr\u003e\nRotor and phase mapping and ablation.pdf\u003cbr\u003e\nRoutine parahisian pacing for bradyarrhythmia using conventional leads.pdf\u003cbr\u003e\nSafety and feasibility of a minimally fluoroscopic approach during pulmonary vein isolation for atrial fibrillation.pdf\u003cbr\u003e\nSafety and feasibility of pulmonary vein isolation for atrial fibrillation in morbidly obese patients with a body mass.pdf\u003cbr\u003e\nSafety of general anesthesia in brugada syndrome.pdf\u003cbr\u003e\nSafety, effectiveness and long-term outcome of maximum voltage-guided approach for cavotricuspid isthmus.mp4\u003cbr\u003e\nSafety, effectiveness and long-term outcome of maximum voltage-guided approach for cavotricuspid isthmus.pdf\u003cbr\u003e\nSarcoidosis.mp4\u003cbr\u003e\nSarcoidosis.pdf\u003cbr\u003e\nScar mapping and ablation.mp4\u003cbr\u003e\nScar mapping and ablation.pdf\u003cbr\u003e\nScuba diving – Is it safe.mp4\u003cbr\u003e\nScuba diving – Is it safe.pdf\u003cbr\u003e\nSecondary atrial fibrillation – Does it recur.mp4\u003cbr\u003e\nSecondary atrial fibrillation – Does it recur.pdf\u003cbr\u003e\nSelection of pacemaker therapy and outcomes in unexplained syncope.pdf\u003cbr\u003e\nSeptal late gadolinium enhancement and conduction delay on ECG in nonischemic dilated cardiomyopathy.pdf\u003cbr\u003e\nSevere functional mitral valve regurgitation and right ventricular dysfunction as independent predictors of poor.pdf\u003cbr\u003e\nSex differences in atrial fibrillation.mp4\u003cbr\u003e\nSex differences in atrial fibrillation.pdf\u003cbr\u003e\nSex differences in prevalence, treatment and outcomes in patients with atrial fibrillation.pdf\u003cbr\u003e\nShort QT phenotype in a family with genetic variants in the KCNH2 and SLC4A3 genes.pdf\u003cbr\u003e\nShould we also screen for obstructive sleep apnea in patients presenting with excessive supraventricular ectopic activity.pdf\u003cbr\u003e\nSide-specific differences in atrial tissue expression are associated with atrial fibrillation and heart failure.pdf\u003cbr\u003e\nSimulating advanced AF-Detection with smartwatches.pdf\u003cbr\u003e\nSingle nucleotide polymorphism rs10465885 in connexin-40 gene is not associated with the transition to permanent.pdf\u003cbr\u003e\nSingle-center experience with zero-fluoroscopy catheter ablation of ventricular arrhthmias.pdf\u003cbr\u003e\nSingle-center experience with zero-fluoroscopy cryoablation of various septal supraventricular tachycardias.pdf\u003cbr\u003e\nSingle-centre experience of percutaneous left atrial appendage closure using the lifetech lambre device for thromboembolic.pdf\u003cbr\u003e\nSleep apnea and arrhythmias.mp4\u003cbr\u003e\nSleep apnea and arrhythmias.pdf\u003cbr\u003e\nSlow pathway localization using high resolution mapping of the triangle of Koch.mp4\u003cbr\u003e\nSlow pathway localization using high resolution mapping of the triangle of Koch.pdf\u003cbr\u003e\nSmartphone and smartwatch arrhythmia detection.mp4\u003cbr\u003e\nSmartphone and smartwatch arrhythmia detection.pdf\u003cbr\u003e\nSnaring, ballooning and more.mp4\u003cbr\u003e\nSnaring, ballooning and more.pdf\u003cbr\u003e\nSodium channels play a key role in pacemaker excitability of the 10-day-old chick embryo right auricle.pdf\u003cbr\u003e\nSpatial control of microdomain calcium release by adrenergic signalling in atrial fibrillation.mp4\u003cbr\u003e\nSpatial control of microdomain calcium release by adrenergic signalling in atrial fibrillation.pdf\u003cbr\u003e\nSpeckle tracking radial strain imaging-guided lead placement for improving response to CRT in patients – Discussion.mp4\u003cbr\u003e\nSpeckle tracking radial strain imaging-guided lead placement for improving response to CRT in patients – Discussion.pdf\u003cbr\u003e\nSpeckle tracking radial strain imaging-guided lead placement for improving response to CRT in patients.mp4\u003cbr\u003e\nSpeckle tracking radial strain imaging-guided lead placement for improving response to CRT in patients.pdf\u003cbr\u003e\nStatistical ranking of electromechanical dyssynchrony parameters for cardiac resynchronisation therapy.pdf\u003cbr\u003e\nStereotactic radiosurgery for ablation of ventricular tachycardia – procedural aspects and toxicity evaluation.mp4\u003cbr\u003e\nStereotactic radiosurgery for ablation of ventricular tachycardia – procedural aspects and toxicity evaluation.pdf\u003cbr\u003e\nStrategies for screening and identifying which patients to protect with the WCD.mp4\u003cbr\u003e\nStrategies for screening and identifying which patients to protect with the WCD.pdf\u003cbr\u003e\nString defibrillator.mp4\u003cbr\u003e\nString defibrillator.pdf\u003cbr\u003e\nStroke.mp4\u003cbr\u003e\nStroke.pdf\u003cbr\u003e\nSubcutaneous ICDs – Screening for eligibility.mp4\u003cbr\u003e\nSubcutaneous ICDs – Screening for eligibility.pdf\u003cbr\u003e\nSubcutaneous implantable cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy.pdf\u003cbr\u003e\nSubcutaneous implantable cardioverter-defibrillator after transvenous lead extraction a single-center experience.pdf\u003cbr\u003e\nSuccessful 1-year outcome of catheter ablation of lone paroxysmal atrial fibrillation assessed by insertable.mp4\u003cbr\u003e\nSuccessful 1-year outcome of catheter ablation of lone paroxysmal atrial fibrillation assessed by insertable.pdf\u003cbr\u003e\nSudden death prevention in patients with significant non-cardiac co-morbidities – How to assist decision-making.mp4\u003cbr\u003e\nSudden death prevention in patients with significant non-cardiac co-morbidities – How to assist decision-making.pdf\u003cbr\u003e\nSudden death risk in non-ischaemic cardiomyopathy – Genotype, phenotype and imaging techniques.mp4\u003cbr\u003e\nSudden death risk in non-ischaemic cardiomyopathy – Genotype, phenotype and imaging techniques.pdf\u003cbr\u003e\nSuper-responders predictors in LV only fusion pacing CRT without RV lead.pdf\u003cbr\u003e\nSupraventricular tachycardia management in 2019.mp4\u003cbr\u003e\nSupraventricular tachycardia management in 2019.pdf\u003cbr\u003e\nSurvival after cardiac resynchronization therapy results from 50,084 implantations.mp4\u003cbr\u003e\nSurvival after cardiac resynchronization therapy results from 50,084 implantations.pdf\u003cbr\u003e\nSympathetic denervation.mp4\u003cbr\u003e\nSympathetic denervation.pdf\u003cbr\u003e\nSymptomatic atrial fibrillation in the elderly – Atrioventricular node ablation is an attractive strategy – CONTRA.mp4\u003cbr\u003e\nSymptomatic atrial fibrillation in the elderly – Atrioventricular node ablation is an attractive strategy – CONTRA.pdf\u003cbr\u003e\nSymptomatic atrial fibrillation in the elderly – Atrioventricular node ablation is an attractive strategy – PRO.mp4\u003cbr\u003e\nSymptomatic atrial fibrillation in the elderly – Atrioventricular node ablation is an attractive strategy – PRO.pdf\u003cbr\u003e\nTamponade.mp4\u003cbr\u003e\nTamponade.pdf\u003cbr\u003e\nTargeting left ventricular lead implantation towards the latest electrical activation improves left ventricular – Discussion.mp4\u003cbr\u003e\nTargeting left ventricular lead implantation towards the latest electrical activation improves left ventricular – Discussion.pdf\u003cbr\u003e\nTargeting left ventricular lead implantation towards the latest electrical activation improves left ventricular.pdf\u003cbr\u003e\nTemporal alteration in atrial electrogram amplitude in patients with atrial fibrillation insights from the IMPACT trial.pdf\u003cbr\u003e\nTemporal association of atrial fibrillation with device based heart failure status in patients with CRT – Discussion.mp4\u003cbr\u003e\nTemporal association of atrial fibrillation with device based heart failure status in patients with CRT – Discussion.pdf\u003cbr\u003e\nTemporal association of atrial fibrillation with device based heart failure status in patients with CRT.mp4\u003cbr\u003e\nTemporal association of atrial fibrillation with device based heart failure status in patients with CRT.pdf\u003cbr\u003e\nThe Apple Heart Study – Discussant Review.mp4\u003cbr\u003e\nThe Apple Heart Study – Discussant Review.pdf\u003cbr\u003e\nThe Apple Heart Study – Discussion.mp4\u003cbr\u003e\nThe Apple Heart Study – Results of a large-scale, App-based study to identify atrial fibrillation using a smartwatch.mp4\u003cbr\u003e\nThe Apple Heart Study – Results of a large-scale, App-based study to identify atrial fibrillation using a smartwatch.pdf\u003cbr\u003e\nThe assessment of the application of pulmonary vein isolation with cryoballoon for non-paroxysmal atrial fibrillation.pdf\u003cbr\u003e\nThe association between atrial fibrillation and alzheimer’s disease fact or fallacy A systematic review and meta-analysis.pdf\u003cbr\u003e\nThe association between cohabiting status and the risk of atrial fibrillation.pdf\u003cbr\u003e\nThe association between insulin resistance and incidence of atrial fibrillation in non-diabetics.pdf\u003cbr\u003e\nThe asymptomatic patient.mp4\u003cbr\u003e\nThe asymptomatic patient.pdf\u003cbr\u003e\nThe best from science and education – Atrial fibrillation.mp4\u003cbr\u003e\nThe best from science and education – Atrial fibrillation.pdf\u003cbr\u003e\nThe best from science and education – Cardiac devices.mp4\u003cbr\u003e\nThe best from science and education – Cardiac devices.pdf\u003cbr\u003e\nThe best from science and education – Ventricular tachycardia.mp4\u003cbr\u003e\nThe best from science and education – Ventricular tachycardia.pdf\u003cbr\u003e\nThe clinical and financial impact of a new nurse-led service for insertion of implantable loop recorders at the university hospital.pdf\u003cbr\u003e\nThe clinical significance of left atrial remodeling after BOX isolation in non-paroxysmal atrial fibrillation.pdf\u003cbr\u003e\nThe CLOSE to CURE study – Discussion.mp4\u003cbr\u003e\nThe CLOSE to CURE study – Discussion.pdf\u003cbr\u003e\nThe degree and spatial distribution of myocardial fibrosis can influence the underlying mechanism of ventricular fibrillation.mp4\u003cbr\u003e\nThe degree and spatial distribution of myocardial fibrosis can influence the underlying mechanism of ventricular fibrillation.pdf\u003cbr\u003e\nThe diagnostic accuracy of a pulse-deriving smartphone application is device independent.mp4\u003cbr\u003e\nThe diagnostic accuracy of a pulse-deriving smartphone application is device independent.pdf\u003cbr\u003e\nThe effect of a continuous positive airways pressure in patients with obstructive sleep apnea with critical disorders.pdf\u003cbr\u003e\nThe effect of a novel small conductance calcium activated potassium channel inhibitor in intact atria and atrial.mp4\u003cbr\u003e\nThe effect of a novel small conductance calcium activated potassium channel inhibitor in intact atria and atrial.pdf\u003cbr\u003e\nThe effect of different peri-procedural anticoagulation regimens on in-hospital outcomes after lead extraction.pdf\u003cbr\u003e\nThe effectiveness of non-pulmonary vein foci targeted ablation for the patient with persistent atrial fibrillation.mp4\u003cbr\u003e\nThe effectiveness of non-pulmonary vein foci targeted ablation for the patient with persistent atrial fibrillation.pdf\u003cbr\u003e\nThe EHRA certification exam – What it is, and why you should have it.mp4\u003cbr\u003e\nThe EHRA certification exam – What it is, and why you should have it.pdf\u003cbr\u003e\nThe elderly CRT-D patient needs a replacement – Downgrade to CRT-P.mp4\u003cbr\u003e\nThe elderly CRT-D patient needs a replacement – Downgrade to CRT-P.pdf\u003cbr\u003e\nThe elderly CRT-D patient needs a replacement – Stick to CRT-D.mp4\u003cbr\u003e\nThe elderly CRT-D patient needs a replacement – Stick to CRT-D.pdf\u003cbr\u003e\nThe GermAn Laser Lead Extraction RegistrY GALLERY.mp4\u003cbr\u003e\nThe GermAn Laser Lead Extraction RegistrY GALLERY.pdf\u003cbr\u003e\nThe impact of qt-interval duration on mortality in a large cohort of community based adult population with a long term follow-up.mp4\u003cbr\u003e\nThe impact of qt-interval duration on mortality in a large cohort of community based adult population with a long term follow-up.pdf\u003cbr\u003e\nThe impact of the mitral annular velocity on the outcome following multiple atrial fibrillation ablation sessions.pdf\u003cbr\u003e\nThe impact of the WCD for patients who choose to wear it.mp4\u003cbr\u003e\nThe impact of the WCD for patients who choose to wear it.pdf\u003cbr\u003e\nThe impact of virtual arrhythmia clinics following catheter ablation for atrial fibrillation.mp4\u003cbr\u003e\nThe impact of virtual arrhythmia clinics following catheter ablation for atrial fibrillation.pdf\u003cbr\u003e\nThe increase of spontaneous action potential frequency in the sinoauricular area strips during mouse embryo development.pdf\u003cbr\u003e\nThe influence of NOAC on sudden neurological death.pdf\u003cbr\u003e\nThe known knowns and the known unknowns of cardiac arrhythmia – The EHRA White Paper.mp4\u003cbr\u003e\nThe known knowns and the known unknowns of cardiac arrhythmia – The EHRA White Paper.pdf\u003cbr\u003e\nThe many faces of subcutaneous ICD under oversensing in real life.mp4\u003cbr\u003e\nThe many faces of subcutaneous ICD under oversensing in real life.pdf\u003cbr\u003e\nThe Medtronic Sprint Fidelis lead history revisited extended follow-up of passive leads.pdf\u003cbr\u003e\nThe next generation visually guided laser balloon ablation system for pulmonary vein isolation first clinical experience.pdf\u003cbr\u003e\nThe OPT-PACE Trial – Discussant Review.mp4\u003cbr\u003e\nThe OPT-PACE Trial – Discussant Review.pdf\u003cbr\u003e\nThe OPT-PACE Ttria – Optimising pacemaker and medical therapy in pacemaker patients for heart failure.mp4\u003cbr\u003e\nThe OPT-PACE Ttria – Optimising pacemaker and medical therapy in pacemaker patients for heart failure.pdf\u003cbr\u003e\nThe prognostic impact of electrocardiographic changes during therapeutic hypothermia in patients with resuscitated cardiac.pdf\u003cbr\u003e\nThe quality of smartphone based heart rhythm monitoring using PPG technology in a large-scale free-living setting.pdf\u003cbr\u003e\nThe relationship between left atrial fibrosis and left ventricular diastolic dysfunction in paroxysmal atrial fibrillation.pdf\u003cbr\u003e\nThe relationship of apelin levels of the blood with left atrium size and its possible role in the development of atrial.pdf\u003cbr\u003e\nThe role of ablation index for typical atrial flutter ablation.pdf\u003cbr\u003e\nThe role of beta1 receptor gene polymorphism in the preference of beta blocker treatment in vasovagal syncope patients.pdf\u003cbr\u003e\nThe tachycardia that is too slow to detect.pdf\u003cbr\u003e\nThe trials-and-errors of antiarrhythmic drug therapy.mp4\u003cbr\u003e\nThe trials-and-errors of antiarrhythmic drug therapy.pdf\u003cbr\u003e\nThe value of the His paced to RV sensed interval in optimising battery longevity in His pacing.mp4\u003cbr\u003e\nThe value of the His paced to RV sensed interval in optimising battery longevity in His pacing.pdf\u003cbr\u003e\nThe world-wide randomized antibiotic envelope infection prevention trial (WRAP-IT) to reduce cardiac implantable.mp4\u003cbr\u003e\nThe world-wide randomized antibiotic envelope infection prevention trial (WRAP-IT) to reduce cardiac implantable.pdf\u003cbr\u003e\nThoracic magnetic resonance imaging performed safely in a pacing-dependent patient with a non-conditional.pdf\u003cbr\u003e\nThromboembolic events associated with cardioversion of atrial fibrillation in patients randomized to antiplatelet.pdf\u003cbr\u003e\nThromboembolic risk in patients with atrial fibrillation and valvular heart disease according to the EHRA Type 2 definition – Discussion.mp4\u003cbr\u003e\nThromboembolic risk in patients with atrial fibrillation and valvular heart disease according to the EHRA Type 2 definition – Discussion.pdf\u003cbr\u003e\nThromboembolic risk in patients with atrial fibrillation and valvular heart disease according to the EHRA Type 2 definition.mp4\u003cbr\u003e\nThromboembolic risk in patients with atrial fibrillation and valvular heart disease according to the EHRA Type 2 definition.pdf\u003cbr\u003e\nThromboembolism after electrical isolation of the left atrial appendage a new indication for interventional closure.pdf\u003cbr\u003e\nTips and tricks of complex accessory pathway ablation.mp4\u003cbr\u003e\nTips and tricks of complex accessory pathway ablation.pdf\u003cbr\u003e\nTools and techniques to facilitate typical flutter ablation.mp4\u003cbr\u003e\nTools and techniques to facilitate typical flutter ablation.pdf\u003cbr\u003e\nTransmission rate of remote monitoring and mortality in patients with a pacemaker.pdf\u003cbr\u003e\nTransvenous lead extraction clinical failure and complications in patients with or without abandoned lead.pdf\u003cbr\u003e\nTransvenous lead extraction of the active fixation coronary sinus lead attain stability after more than 4 years dwelling time.pdf\u003cbr\u003e\nTransvenous lead extraction sixteen-year experience at a single centre.pdf\u003cbr\u003e\nTransvenous leads extraction in elderly.pdf\u003cbr\u003e\nTripling survival rates after sudden cardiac arrest before the cath lab – How did we do that and how can we do even better.mp4\u003cbr\u003e\nTripling survival rates after sudden cardiac arrest before the cath lab – How did we do that and how can we do even better.pdf\u003cbr\u003e\nTwo hours of subclinical atrial fibrillation – Start anticoagulation.mp4\u003cbr\u003e\nTwo hours of subclinical atrial fibrillation – Start anticoagulation.pdf\u003cbr\u003e\nTwo-year follow-up of one-stage left unilateral thoracoscopic epicardial and transcatheter endocardial ablation.pdf\u003cbr\u003e\nUltra-low radiation dose 3D rotational angiography for left atrial modelling during pulmonary vein isolation.pdf\u003cbr\u003e\nUltrasound guided axillary vein puncture for cardiac devices implantation, time to rethink the vascular access technique.pdf\u003cbr\u003e\nUnder direct vision minimally invasive thoracoscopy during lead extraction.pdf\u003cbr\u003e\nUnexpected technical problems during transvenous lead extraction. The experience among 2841 TLE procedures.pdf\u003cbr\u003e\nUnexplained sudden death.mp4\u003cbr\u003e\nUnexplained sudden death.pdf\u003cbr\u003e\nUninterrupted edoxaban versus vitamin k antagonists for ablation of atrial fibrillation the ELIMINATE-AF Trial.mp4\u003cbr\u003e\nUninterrupted edoxaban versus vitamin k antagonists for ablation of atrial fibrillation the ELIMINATE-AF Trial.pdf\u003cbr\u003e\nUpstream therapy using preoperative renin-angiotensin system inhibitors in prevention of postoperative atrial.pdf\u003cbr\u003e\nUse of Ablation Index significantly reduces the incidence of cardiac tamponade complicating pulmonary vein isolation.pdf\u003cbr\u003e\nUse of discriminators across different manufacturers.pdf\u003cbr\u003e\nUse of echocardiography, cardiac CT and cardiac MR to guide left ventricular lead placement in cardiac resynchronization.pdf\u003cbr\u003e\nUse of novel electrogram to detect critical isthmus and abnormal potentials for ablation in ventricular tachycardia.mp4\u003cbr\u003e\nUse of novel electrogram to detect critical isthmus and abnormal potentials for ablation in ventricular tachycardia.pdf\u003cbr\u003e\nUsefulness of a standard 12-lead electrocardiogram to predict the eligibility for a subcutaneous defibrillator based on.pdf\u003cbr\u003e\nUsefulness of atropine for the decrease of the hospital stay in patients candidates to implant of pacemakers in the context.pdf\u003cbr\u003e\nUsefulness of CHADS2-VASc score in predicting stroke in patients with atrial fibrillation and heart failure.pdf\u003cbr\u003e\nUsing artificial intelligence to identify sites where local ablation terminates persistent atrial fibrillation.mp4\u003cbr\u003e\nUsing artificial intelligence to identify sites where local ablation terminates persistent atrial fibrillation.pdf\u003cbr\u003e\nUtility of accelerometer programmation in leadless pacemaker regardind location.pdf\u003cbr\u003e\nValidation of a novel electrophysiology mapping simulator system.pdf\u003cbr\u003e\nValidation of an easy-to-use, operator-independent, clinical model to predict the left vs. right ventricular outflow.pdf\u003cbr\u003e\nValidation of the CaRDIA-X algorithm (Cardiac Rhythm Device Identification Algorithm using X-Rays), in a tertiary hospital.pdf\u003cbr\u003e\nValidation study of a pulse-deriving wrist band using spot-check measurements to detect atrial fibrillation.pdf\u003cbr\u003e\nValue of baseline 12 lead- ECG in predicting syncope caused by arrhythmia in patients wearing an implantable loop recorder.pdf\u003cbr\u003e\nValue of cine magnetic resonance imaging for the characterization of the left atrium in patients referred for catheter.pdf\u003cbr\u003e\nValue of PET and CMR in predicting ventricular arrhythmias in patients with ischaemic cardiomyopathy.mp4\u003cbr\u003e\nValue of PET and CMR in predicting ventricular arrhythmias in patients with ischaemic cardiomyopathy.pdf\u003cbr\u003e\nValue of routine use of intracardiac echocardiography and routine ultrasound guided venipuncture.pdf\u003cbr\u003e\nVascular complication.mp4\u003cbr\u003e\nVascular complication.pdf\u003cbr\u003e\nVenous thrombosis in patients after catheter ablation.Efficacy and safety of enoxaparin therapy.pdf\u003cbr\u003e\nVentricular arrhythmias from unusual right ventricular and left ventricular locations.mp4\u003cbr\u003e\nVentricular arrhythmias from unusual right ventricular and left ventricular locations.pdf\u003cbr\u003e\nVentricular arrhythmias in obstrutive sleep apnea patients.pdf\u003cbr\u003e\nVentricular arrhythmias related to the conduction system.mp4\u003cbr\u003e\nVentricular arrhythmias related to the conduction system.pdf\u003cbr\u003e\nVentricular tachycardia ablation in the MRI environment.mp4\u003cbr\u003e\nVentricular tachycardia ablation in the MRI environment.pdf\u003cbr\u003e\nVentricular tachycardia ablation.mp4\u003cbr\u003e\nVentricular tachycardia ablation.pdf\u003cbr\u003e\nVentricular tachycardia mapping – Common challenges, new tools \u0026amp; approaches.mp4\u003cbr\u003e\nVentricular tachycardia mapping – Common challenges, new tools \u0026amp; approaches.pdf\u003cbr\u003e\nVentricular tachycardia prediction in patients with implantable cardioverter-defibrillators for primary prevention of sudden.pdf\u003cbr\u003e\nVirtual heart anatomy and related heart structures.mp4\u003cbr\u003e\nVisualisation of myocardial lesion formation in the first 60 minutes after epicardial electroporation ablation.pdf\u003cbr\u003e\nWait-and-see versus acute cardioversion in recent-onset AF – Discussion.mp4\u003cbr\u003e\nWait-and-see versus acute cardioversion in recent-onset AF – Discussion.pdf\u003cbr\u003e\nWe can stop oral anticoagulation in moderate risk patients after successful ablation – CONTRA.mp4\u003cbr\u003e\nWe can stop oral anticoagulation in moderate risk patients after successful ablation – CONTRA.pdf\u003cbr\u003e\nWe can stop oral anticoagulation in moderate risk patients after successful ablation – PRO.mp4\u003cbr\u003e\nWe can stop oral anticoagulation in moderate risk patients after successful ablation – PRO.pdf\u003cbr\u003e\nWearable cardioverter defibrillator – Programming and troubleshooting.mp4\u003cbr\u003e\nWearable cardioverter defibrillator – Programming and troubleshooting.pdf\u003cbr\u003e\nWelcome address.mp4\u003cbr\u003e\nWhat about the right atrium Quantification of right atrial fibrosis by magnetic resonance with late gadolinium enhancement.pdf\u003cbr\u003e\nWhat can be learned from ICD use in congenital heart disease.mp4\u003cbr\u003e\nWhat can be learned from ICD use in congenital heart disease.pdf\u003cbr\u003e\nWhat can the adult electrophysiologist learn from the paediatric electrophysiologist when pacing patients.mp4\u003cbr\u003e\nWhat can the adult electrophysiologist learn from the paediatric electrophysiologist when pacing patients.pdf\u003cbr\u003e\nWhat is the role of endocardial right ventricular pacemaker lead in the development of tricuspid regurgitation.pdf\u003cbr\u003e\nWhen disaster strikes.mp4\u003cbr\u003e\nWhen disaster strikes.pdf\u003cbr\u003e\nWhen is it appropriate to stop non-vitamin K antagonist oral anticoagulants before catheter ablation of atrial fibrillation.pdf\u003cbr\u003e\nWhen should I consider endocardial pacing.mp4\u003cbr\u003e\nWhen should I consider endocardial pacing.pdf\u003cbr\u003e\nWide QRS with one-to-one conduction.mp4\u003cbr\u003e\nWide QRS with one-to-one conduction.pdf\u003cbr\u003e\nWide-area left atrial appendage isolation in patients not responding to pulmonary-vein-isolation benefit and risks.mp4\u003cbr\u003e\nWide-area left atrial appendage isolation in patients not responding to pulmonary-vein-isolation benefit and risks.pdf\u003cbr\u003e\nWitnessed and unwitnessed sudden cardiac death a nationwide cohort study in denmark.pdf\u003cbr\u003e\nWorking as an advanced nurse practitioner – Qualifications needed.mp4\u003cbr\u003e\nWorking as an advanced nurse practitioner – Qualifications needed.pdf\u003cbr\u003e\nWorking Group on E-Cardiology.pdf\u003cbr\u003e\nWRAP-IT – Discussant Review.mp4\u003cbr\u003e\nWRAP-IT – Discussant Review.pdf\u003cbr\u003e\nZero fluoroscopy ablation among different arrhythmias in an electrophysiology unit efficiency and security study.pdf\u003cbr\u003e\nZero fluoroscopy approach in catheter ablation procedures review of a tertiary centre cohort.pdf\u003cbr\u003e\nZero-fluoroscopy radiofreqeuncy and cryo-ablation in pediatric population.pdf\u003cbr\u003e\nZero-fluoroscopy slow-pathway AVNRT ablation with 3D electro-anatomical mapping systems as the gold standard.pdf\u003cbr\u003e\nZigzag bipolar radiofrequency catheter ablation.pdf\u003cbr\u003e\nalways combined endocardial-epicardial first.mp4\u003cbr\u003e\nalways combined endocardial-epicardial first.pdf\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\n","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954658578530,"sku":"MED-AMB07698","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/PhotoFixerBot_22-27-29_UTC.jpg?v=1779381835","url":"https:\/\/meducourse.com\/products\/european-society-of-cardiology-ehra-2019","provider":"Meducourse","version":"1.0","type":"link"}